WO2013118852A1 - Allergen inhibitor, allergen-inhibiting product, allergen inhibition method, and use as allergen inhibitor - Google Patents

Allergen inhibitor, allergen-inhibiting product, allergen inhibition method, and use as allergen inhibitor Download PDF

Info

Publication number
WO2013118852A1
WO2013118852A1 PCT/JP2013/052971 JP2013052971W WO2013118852A1 WO 2013118852 A1 WO2013118852 A1 WO 2013118852A1 JP 2013052971 W JP2013052971 W JP 2013052971W WO 2013118852 A1 WO2013118852 A1 WO 2013118852A1
Authority
WO
WIPO (PCT)
Prior art keywords
allergen
styrene
sulfonic acid
acid group
inhibitor
Prior art date
Application number
PCT/JP2013/052971
Other languages
French (fr)
Japanese (ja)
Inventor
鈴木 太郎
周知 佐藤
藤原 昭彦
Original Assignee
積水化学工業株式会社
積水ポリマテック株式会社
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 積水化学工業株式会社, 積水ポリマテック株式会社 filed Critical 積水化学工業株式会社
Publication of WO2013118852A1 publication Critical patent/WO2013118852A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • A61P31/08Antibacterial agents for leprosy
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F212/00Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by an aromatic carbocyclic ring
    • C08F212/02Monomers containing only one unsaturated aliphatic radical
    • C08F212/04Monomers containing only one unsaturated aliphatic radical containing one ring
    • C08F212/14Monomers containing only one unsaturated aliphatic radical containing one ring substituted by heteroatoms or groups containing heteroatoms
    • C08F212/30Sulfur
    • DTEXTILES; PAPER
    • D06TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
    • D06MTREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
    • D06M15/00Treating fibres, threads, yarns, fabrics, or fibrous goods made from such materials, with macromolecular compounds; Such treatment combined with mechanical treatment
    • D06M15/19Treating fibres, threads, yarns, fabrics, or fibrous goods made from such materials, with macromolecular compounds; Such treatment combined with mechanical treatment with synthetic macromolecular compounds
    • D06M15/21Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds
    • D06M15/227Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds of hydrocarbons, or reaction products thereof, e.g. afterhalogenated or sulfochlorinated
    • D06M15/233Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds of hydrocarbons, or reaction products thereof, e.g. afterhalogenated or sulfochlorinated aromatic, e.g. styrene
    • DTEXTILES; PAPER
    • D06TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
    • D06MTREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
    • D06M15/00Treating fibres, threads, yarns, fabrics, or fibrous goods made from such materials, with macromolecular compounds; Such treatment combined with mechanical treatment
    • D06M15/19Treating fibres, threads, yarns, fabrics, or fibrous goods made from such materials, with macromolecular compounds; Such treatment combined with mechanical treatment with synthetic macromolecular compounds
    • D06M15/21Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds
    • D06M15/263Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds of unsaturated carboxylic acids; Salts or esters thereof
    • DTEXTILES; PAPER
    • D06TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
    • D06MTREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
    • D06M15/00Treating fibres, threads, yarns, fabrics, or fibrous goods made from such materials, with macromolecular compounds; Such treatment combined with mechanical treatment
    • D06M15/19Treating fibres, threads, yarns, fabrics, or fibrous goods made from such materials, with macromolecular compounds; Such treatment combined with mechanical treatment with synthetic macromolecular compounds
    • D06M15/21Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds
    • D06M15/356Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds of other unsaturated compounds containing nitrogen, sulfur, silicon or phosphorus atoms
    • D06M15/3566Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds of other unsaturated compounds containing nitrogen, sulfur, silicon or phosphorus atoms containing sulfur
    • DTEXTILES; PAPER
    • D06TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
    • D06MTREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
    • D06M16/00Biochemical treatment of fibres, threads, yarns, fabrics, or fibrous goods made from such materials, e.g. enzymatic

Definitions

  • the present invention can suppress the reaction of allergens such as pollen of vegetation such as cedar, mites, and indoor dust with specific antibodies, and is unlikely to cause unexpected discoloration or discoloration under daily use conditions.
  • the present invention relates to an allergen inhibitor that hardly causes color transfer, and an allergen-suppressed product obtained by treating the allergen inhibitor with an allergen object.
  • allergic diseases such as atopic dermatitis, bronchial asthma and allergic rhinitis have become a problem.
  • the main causes of this allergic disease are mites living in the house, especially leopard mite allergens (Der1, Der2), which are abundant in indoor dust, and cedar pollen floating in the air mainly in spring. This is because allergens such as allergens (Cry j1, Cry j2) are increasing in the living space.
  • cedar pollen allergens Cry j1 and Cry j2 are glycoproteins having a molecular weight of about 40 kDa and a molecular weight of about 37 kDa, respectively. These cedar pollen allergens are in vitro as foreign substances when attached to the nasal mucosa. It is recognized and causes an inflammatory response.
  • allergen Since allergen is a protein, it is considered that allergen loses allergenicity when it is denatured with heat, strong acid or strong alkali. However, allergens are very stable and are not easily denatured by oxidizing agents, reducing agents, heat, alkalis, acids, etc. that can be used safely at home (see Non-Patent Document 1).
  • allergens present in an object that is contaminated with allergens are to be denatured
  • the objects that are contaminated with allergens such as tatami mats, carpets, floors, furniture (sofas, cloth chairs, tables), bedding ( Beds, futons, sheets), interior items (seats, child seats), vehicle interior materials (ceiling materials, etc.), kitchen items, baby items, curtains, wallpaper, towels, clothing, stuffed animals, other textile products, air purifiers ( The main body and filter) may be damaged depending on conditions.
  • Patent Document 3 proposes an allergen inhibitor containing an aromatic hydroxy compound as an active ingredient, which has improved the problem of coloring the object, but when processed into a light-colored object such as white. Coloration may occur and was not sufficient.
  • Patent Document 4 proposes an allergen inhibitor containing an allergen inhibitor compound, in which the allergen inhibitor compound is a sodium sulfonate salt of a p-styrenesulfonic acid homopolymer.
  • Patent Document 5 proposes an allergen deactivator comprising a polymer compound having a styrene sulfonic acid unit. Specifically, in the examples, only the polymer compound having a styrene sulfonic acid ratio of 50 to 70% by weight is proposed. Is used as an allergen deactivator and its inactivation effect has been measured, but the deactivation effect has not been measured for polymer compounds having a styrenesulfonic acid ratio other than 50 to 70% by weight.
  • the allergen inactive agent when the styrene sulfonic acid ratio in the polymer compound is 50 to 70% by weight, when the allergen inactive agent is processed into, for example, a textile product such as clothing, the allergen inactive agent causes the fiber. There is a problem that the color of the product is transferred to another product and contaminates the other product.
  • the present invention effectively suppresses allergens from reacting with specific antibodies, can reduce allergy symptoms or prevent their occurrence, and is unlikely to cause unexpected discoloration or discoloration under daily use conditions. Furthermore, the present invention provides an allergen inhibitor that hardly causes color transfer, and an allergen-suppressed product obtained by treating the allergen inhibitor with an allergen object.
  • the allergen inhibitor of the present invention contains a styrene polymer containing 20 to 45% by weight of a monomer component having the structural formula represented by the general formula (1) as an active ingredient.
  • R 1 to R 5 are each hydrogen, a sulfonic acid group or a sulfonic acid group salt, and at least one of R 1 to R 5 is a sulfonic acid group or a sulfonic acid group salt. is there.
  • the allergen inhibitor refers to those having an allergen inhibitory effect
  • the “allergen inhibitory effect” refers to leopard mite allergens (Der1, Der2), cedar pollen allergens (Cryj1, Cryj2) floating in the air
  • the allergens such as allergens (Can f1, Fel d1) caused by dogs and cats are denatured or adsorbed to suppress the reactivity of allergens to specific antibodies.
  • a method for confirming such an allergen inhibitory effect for example, a method for measuring the amount of allergen by ELISA using an ELISA kit commercially available from Nitinichi Pharmaceutical Co., Ltd., an allergen measuring instrument (commercially available from Sumika Enviro Science Co., Ltd.) And a method for evaluating allergenicity using the name “Mighty Checker”).
  • a method for producing a styrenic polymer containing 20 to 45% by weight of the monomer component having the structural formula represented by the general formula (1) is, for example, (1) a single unit of the structural formula represented by the general formula (1).
  • Sulfonated and introduced sulfonic acid group (—SO 3 H) is neutralized with an aqueous alkaline solution to form a sulfonic acid group as a salt; (4) a monomer having the structural formula represented by the general formula (1); A part of the benzene ring in the copolymerization of this monomer with another polymerizable monomer is sulfonated, and the introduced sulfonic acid group (—SO 3 H) is neutralized with an alkaline aqueous solution to remove the sulfonic acid group.
  • polystyrene sulfonic acid polystyrene sulfonic acid, styrene sulfonic acid and this In the copolymer, or salts of these sulfonic acids with other copolymerizable monomers, a method of desulfonation part of the sulfonic acid group.
  • alkaline aqueous solution include sodium hydroxide, potassium hydroxide, magnesium hydroxide, and ammonium hydroxide.
  • R 1 to R 5 are each hydrogen (—H), a sulfonic acid group (—SO 3 H), or a salt of a sulfonic acid group, of R 1 to R 5 It is necessary that at least one of these is a sulfonic acid group or a salt of a sulfonic acid group. This is because in the general formula (1), the allergen inhibitor does not exhibit an allergen inhibitory effect unless it has a sulfonic acid group or a salt of a sulfonic acid group as a substituent.
  • the salt of a sulfonic acid group for example, -SO 3 Na, -SO 3 K , -SO 3 Li, (- SO 3) 2 Ca, (- SO 3) 2 Mg, -SO 3 - NH 4 + can be mentioned
  • the monovalent salt of a sulfonic acid group is preferred because the degree of freedom of the salt of the sulfonic acid group is high, the allergen denaturing effect or adsorption effect is high, and the allergen inhibitory effect of the allergen inhibitor is high, and —SO 3 Na, -SO 3 K, -SO 3 Li, -SO 3 - NH 4 + are more preferable, -SO 3 Na, -SO 3 - NH 4 + is particularly preferred.
  • the monovalent salt of the sulfonic acid group is represented by —SO 3 M, and M is a monovalent cation. Examples of M include Na + , K + , Li + , NH 4 + and the like.
  • R 3 is a sulfonic acid group or a salt of a sulfonic acid group
  • R 1 , R 2 , R 4 and R 5 are hydrogen. preferable.
  • Examples of the monomer represented by the general formula (1) include o-styrene sulfonic acid, o-sodium styrene sulfonate, m-styrene sulfonic acid, sodium m-styrene sulfonate, and p-styrene sulfonic acid.
  • sodium styrene sulfonate, potassium styrene sulfonate, lithium styrene sulfonate, ammonium styrene sulfonate is more preferred, sodium p- styrenesulfonate are particularly preferable.
  • Examples of the monomer component other than the monomer component of the structural formula represented by the general formula (1) in the styrenic polymer include alkyl acrylates such as methyl acrylate, ethyl acrylate and 2-hydroxyethyl acrylate, methyl Methacrylate, ethyl methacrylate, alkyl methacrylate such as 2-hydroxyethyl methacrylate, vinyl alkyl ether such as vinyl methyl ether, vinyl acetate, ethylene, propylene, butylene, butadiene, diisobutylene, vinyl chloride, vinylidene chloride, 2-vinylnaphthalene, styrene, Acrylonitrile, acrylic acid, sodium acrylate, methacrylic acid, sodium methacrylate, maleic acid, fumaric acid, maleic anhydride, acrylamide, methacrylamide, diacetone Rylamide, vinyltoluene, xylene sulfonic acid, vinyl pyridine, vinyl
  • Styrenic polymers are preferably linear because they have a high degree of freedom in the main chain and a high allergen-modifying or adsorbing effect.
  • the allergen inhibitory effect of the allergen inhibitor is lowered.
  • the styrene polymer of the allergen inhibitor if the content of the monomer component of the structural formula represented by the general formula (1) is large, the allergen inhibitor becomes easily compatible with pigments such as pigments and dyes. Is easy to drop off. As a result, for example, when dark fibers such as black are treated with an allergen inhibitor, the fibers will rub against other products in daily life, causing the dark color of the fibers to move to other products and contaminating other products. To do. Therefore, the content of the monomer component of the structural formula represented by the general formula (1) in the styrene polymer of the allergen inhibitor is limited to 20 to 45% by weight, and preferably 25 to 45% by weight.
  • Examples of the styrene polymer containing the monomer component having the structural formula represented by the general formula (1) include p-styrene sulfonate-styrene copolymer and o-styrene sulfonate-styrene copolymer.
  • Styrene sulfonate-styrene copolymer such as m-styrene sulfonate-styrene copolymer, styrene sulfonate-styrene sulfonic acid-styrene terpolymer, p-styrene sulfonic acid or a salt thereof
  • a copolymer of at least one monomer and maleic acid a copolymer of at least one monomer of p-styrenesulfonic acid or a salt thereof and 2-hydroxyethyl methacrylate, p-styrenesulfonic acid Or a copolymer of at least one monomer of its salt and acrylic acid, at least one of p-styrenesulfonic acid or its salt Copolymer of methacrylic acid monomer, copolymer of at least one monomer of p-styrene sulfonic acid or its salt and
  • the said styrenic polymer may be used independently, or 2 or more types may be used together.
  • the styrene sulfonate-styrene copolymer is not particularly limited.
  • examples include calcium sulfonate-styrene copolymer, ammonium styrenesulfonate-styrene copolymer, magnesium styrenesulfonate-styrene copolymer, potassium styrenesulfonate-styrene copolymer, lithium styrenesulfonate-styrene copolymer.
  • the styrene sulfonate-styrene copolymer may be used alone or in combination of two or more.
  • the allergen inhibitory effect of the allergen inhibitor may be reduced.
  • the allergen inhibitor becomes easily compatible with a pigment such as a pigment or a dye, and the pigment is easily removed.
  • a pigment such as a pigment or a dye
  • the content of the styrene sulfonate component in the styrene sulfonate-styrene copolymer is limited to 20 to 45% by weight, and preferably 25 to 45% by weight.
  • the styrene sulfonate-styrene sulfonic acid-styrene terpolymer is not particularly limited.
  • styrene terpolymer potassium styrene sulfonate-styrene sulfonic acid-styrene terpolymer, lithium styrene sulfonate-styrene sulfonic acid-styrene terpolymer, sodium styrene sulfonate-styrene sulfonic acid- Styrene terpolymers are more preferred, and p-sodium styrene sulfonate-styrene sulfonic acid-styrene terpolymers are particularly preferred.
  • the styrene sulfonate-styrene sulfonic acid-styrene terpolymer may be used alone or in combination of two or more.
  • the allergen inhibitory effect of the allergen inhibitor may be reduced. If the content of the styrene sulfonate component in the styrene sulfonate-styrene sulfonate-styrene terpolymer is small, the allergen inhibitory effect of the allergen inhibitor may be reduced. If the content of the styrene sulfonate component in the styrene sulfonate-styrene sulfonic acid-styrene terpolymer is high, the allergen inhibitor will be easily compatible with pigments such as pigments and dyes, and the pigments will easily fall off. Become.
  • the content of the styrene sulfonate component in the styrene sulfonate-styrene sulfonic acid-styrene terpolymer is limited to 20 to 45% by weight, and preferably 25 to 45% by weight.
  • the acidity of the styrene sulfonate-styrene sulfonic acid-styrene terpolymer becomes strong, Since the allergen target to be treated with the allergen inhibitor may be damaged, it is preferably 10% by weight or less, more preferably 3% by weight or less.
  • sulfonated polystyrene examples include polymers in which a part or all of the sulfonic acid group of a polymer obtained by sulfonating a part of the polystyrene benzene ring is a salt, and a part of the polystyrene benzene ring is sulfonated.
  • a polymer in which all of the sulfonic acid groups of the obtained polymer are salts is preferred.
  • polystyrene sulfonated polymer examples include a polymer in which all of the sulfonic acid groups of a polymer obtained by sulfonating a part of the polystyrene benzene ring are sodium salts, and a polymer in which a part of the polystyrene benzene ring is sulfonated.
  • the allergen inhibitory effect of the allergen inhibitor may be reduced. If the content of the styrene sulfonate component in the polystyrene sulfonated product is large, the allergen inhibitor becomes easily compatible with pigments such as pigments and dyes, and the pigments easily fall off. As a result, for example, when dark fibers such as black are treated with an allergen inhibitor, the fibers will rub against other products in daily life, causing the dark color of the fibers to move to other products and contaminating other products. There are things to do.
  • the content of the styrene sulfonate component in the sulfonated polystyrene is limited to 20 to 45% by weight, and preferably 25 to 45% by weight.
  • the allergen object to be treated may be damaged, so that it is preferably 10% by weight or less, and more preferably 3% by weight or less.
  • the allergen inhibitory effect of the allergen inhibitor may decrease, so 2000 or more is preferable, and 20000 or more is more preferable, but if it is too high, the allergen inhibitor. Is less than 1,000,000.
  • the weight average molecular weight of the styrene polymer refers to a peak top value when measured by size exclusion chromatography using sodium polystyrene sulfonate as a standard substance.
  • the weight average molecular weight of the styrene polymer can be measured, for example, under the following conditions.
  • the allergen inhibitor can be obtained by preparing a predetermined type and a predetermined amount of monomer according to the constituent components and copolymerizing the monomer in a general manner. Further, the allergen inhibitor can be obtained by sulfonating a part of a benzene ring of a copolymer having a styrene skeleton such as a styrene-maleic acid copolymer or polystyrene, and neutralizing the introduced sulfonic acid group with an alkaline aqueous solution. Can also be obtained.
  • a styrene sulfonate-styrene copolymer can be obtained by sulfonating a part of the benzene ring of polystyrene and neutralizing all sulfonic acid groups bonded to the benzene ring with an alkaline aqueous solution.
  • Part of the benzene ring of polystyrene is sulfonated, and part of the sulfonic acid group bonded to the benzene ring is neutralized with an alkaline aqueous solution to obtain a styrenesulfonate-styrenesulfonic acid-styrene copolymer.
  • the alkaline aqueous solution include sodium hydroxide, potassium hydroxide, magnesium hydroxide, and ammonium hydroxide.
  • the sulfonation of polystyrene can be carried out in a known manner, and examples thereof include a method using sulfur trioxide or concentrated sulfuric acid.
  • the average particle size of the styrenic polymer is not particularly limited, but is preferably from 0.01 to 30 ⁇ m from the viewpoint of design of an allergen-suppressed product obtained by treating an allergen object with an allergen inhibitor. A thickness of 05 to 10 ⁇ m is more preferable.
  • the average particle size of the styrenic polymer is a value measured by a particle size distribution measuring device.
  • the particle size distribution measuring apparatus an apparatus commercially available from HORIBA Ltd. under the trade name “LA-950V2” can be used.
  • the allergen inhibitor is water-insoluble, the allergen may be present or an allergen may be present in the future, such as a household article, that is, an object for which allergen is desired to be suppressed (hereinafter, “ Even when the "allergen object” is in contact with water, the allergen inhibitor can be prevented from dissolving and disappearing in water, and the allergen inhibitory effect of the allergen inhibitor product described below can be maintained over a long period of time. It can be sustained stably. Therefore, the allergen inhibitor is preferably water-insoluble. Human bodies and animals are excluded from allergen objects. Further, when the allergen inhibitor is water-soluble, it is preferable to make it water-insoluble.
  • water-insoluble means that the number of grams that can be dissolved in 100 g of water having a pH of 5 to 9 at 20 ° C. (hereinafter referred to as “solubility”) is 1 or less. Is called water-soluble.
  • a method for making an allergen inhibitor water-insoluble a method for crosslinking a styrene polymer by containing a curing agent in a water-soluble styrene polymer, a method for fixing a water-soluble styrene polymer to a carrier Etc.
  • the curing agent for the styrenic polymer is not particularly limited as long as the styrenic polymer can be crosslinked.
  • amine compounds compounds such as polyaminoamide compounds synthesized from amine compounds, tertiary amine compounds, Examples include imidazole compounds, hydrazide compounds, melamine compounds, acid anhydrides, phenolic compounds, thermal latent cationic polymerization catalysts, photolatent cationic polymerization initiators, dicyanamide and derivatives thereof, and divinylbenzene. More than one species may be used in combination.
  • the amine compound is not particularly limited.
  • aliphatic amines such as ethylenediamine, diethylenetriamine, triethylenetetramine, tetraethylenepentamine, polyoxypropylenediamine, polyoxypropylenetriamine, and derivatives thereof; mensendiamine, isophorone Diamine, bis (4-amino-3-methylcyclohexyl) methane, diaminodicyclohexylmethane, bis (aminomethyl) cyclohexane, N-aminoethylpiperazine, 3,9-bis (3-aminopropyl) 2,4,8,10 Alicyclic amines such as tetraoxaspiro (5,5) undecane and derivatives thereof; m-xylenediamine, ⁇ - (m-aminophenyl) ethylamine, ⁇ - (p-aminophenyl) ethylamine, m-phenylenedia And aromatic amines
  • the compound synthesized from the amine compound is not particularly limited.
  • a ketimine compound synthesized from the amine compound and a ketone compound and a derivative thereof synthesized from the amine compound and a compound such as an epoxy compound, urea, thiourea, an aldehyde compound, a phenol compound, or an acrylic compound.
  • Polyamino compounds and derivatives thereof are exemplified.
  • the tertiary amine compound is not particularly limited.
  • the imidazole compound is not particularly limited, and examples thereof include 2-methylimidazole, 2-ethyl-4-methylimidazole, 2-undecylimidazole, 2-heptadecylimidazole, 2-phenylimidazole and derivatives thereof. Can be mentioned.
  • the hydrazide compound is not particularly limited, and for example, 1,3-bis (hydrazinocarboethyl) -5-isopropylhydantoin, 7,11-octadecadien-1,18-dicarbohydrazide, eicosan Examples thereof include acid dihydrazide, adipic acid dihydrazide and derivatives thereof.
  • the melamine compound is not particularly limited, and examples thereof include 2,4-diamino-6-vinyl-1,3,5-triazine and derivatives thereof.
  • the acid anhydride is not particularly limited.
  • phthalic acid anhydride trimellitic acid anhydride, pyromellitic acid anhydride, benzophenone tetracarboxylic acid anhydride, ethylene glycol bisanhydro trimellitate, glycerol tris Anhydrotrimellitate, methyltetrahydrophthalic anhydride, tetrahydrophthalic anhydride, nadic anhydride, methylnadic anhydride, trialkyltetrahydrophthalic anhydride, hexahydrophthalic anhydride, methylhexahydrophthalic anhydride, 5- ( 2,5-dioxotetrahydrofuryl) -3-methyl-3-cyclohexene-1,2-dicarboxylic acid anhydride, trialkyltetrahydrophthalic anhydride-maleic anhydride adduct, dodecenyl succinic anhydride, polyazeline acid anhydride Polyd
  • the phenol compound is not particularly limited, and examples thereof include phenol novolak, o-cresol novolak, p-cresol novolak, t-butylphenol novolak, dicyclopentadiene cresol and derivatives thereof.
  • the thermal latent cationic polymerization catalyst is not particularly limited.
  • examples include ionic thermal latent cationic polymerization catalysts such as salts and benzylphosphonium salts; nonionic thermal latent cationic polymerization catalysts such as N-benzylphthalimide and aromatic sulfonic acid esters.
  • the photolatent cationic polymerization initiator is not particularly limited.
  • Ionic photolatent cationic polymerization initiators such as onium salts such as aromatic sulfonium salts and organometallic complexes such as iron-allene complexes, titanocene complexes and arylsilanol-aluminum complexes; nitrobenzyl esters, sulfonic acid derivatives,
  • Nonionic photolatent cationic polymerization initiators such as phosphoric acid ester, phenolsulfonic acid ester, diazonaphthoquinone, N-hydroxyimide sulfonate and the like can be mentioned.
  • the carrier for fixing the styrenic polymer is not particularly limited, and examples thereof include inorganic carriers such as talc, bentonite, clay, kaolin, diatomaceous earth, silica, vermulite, perlite, and organic carriers such as polyethylene and polypropylene. Examples thereof include a polymer carrier.
  • the form of the organic polymer carrier is not particularly limited, and examples thereof include fine particles, fibers, sheets, films, and foams.
  • the styrenic polymer When the styrenic polymer is supported on the foam, the styrenic polymer may be supported before foaming of the foamable molded article that is the raw material of the foam, or the styrenic polymer may be supported after foaming. .
  • the method for fixing the styrenic polymer to the support is not particularly limited.
  • a method for adsorbing the styrenic polymer to the support, a chemical bond such as grafting, or a bond with a binder may be used.
  • Examples thereof include a method of fixing to a carrier.
  • the allergen inhibitor of the present invention may contain formulation adjuvants such as a dispersant, an emulsifier, an antioxidant, an ultraviolet absorber, and a dye transfer inhibitor as long as the effectiveness of the allergen suppressing effect is not impaired.
  • acaricides, bactericides, fungicides, deodorants and the like may be contained.
  • the dye transfer inhibitor is not particularly limited, and examples thereof include salts such as calcium chloride, water-soluble cationic compounds, polyvinyl pyrrolidone, polyvinyl pyridine betaine, and polyamine N-oxide polymers.
  • the procedure for using the allergen inhibitor will be described.
  • a general use method such as a spray type, an aerosol type, a smoke type, a heat transpiration type, or a mixture in a matrix can be used.
  • the allergen inhibitor is dissolved or dispersed in a solvent to form an allergen inhibitor solution, and an allergen inhibitor solution is mixed with an aqueous solvent, oil agent, emulsion, suspension, etc. to make the allergen inhibitor spray type.
  • a spray type means the usage method which applies a pressure to the allergen inhibitor solution under normal pressure, and sprays an allergen inhibitor in the shape of a mist.
  • the solvent examples include water (preferably ion-exchanged water), alcohols (methyl alcohol, ethyl alcohol, propyl alcohol, etc.), hydrocarbons (toluene, xylene, methylnaphthalene, kerosene, cyclohexane, etc.), Examples include ethers (diethyl ether, tetrahydrofuran, dioxane, etc.), ketones (acetone, methyl ethyl ketone, etc.), amides (N, N-dimethylformamide, etc.).
  • water preferably ion-exchanged water
  • alcohols methyl alcohol, ethyl alcohol, propyl alcohol, etc.
  • hydrocarbons toluene, xylene, methylnaphthalene, kerosene, cyclohexane, etc.
  • ethers diethyl ether, tetrahydrofuran, dioxane, etc.
  • ketones
  • the allergen inhibitor can be made into an aerosol type. .
  • a solid carrier talc, bentonite, clay, kaolin, diatomaceous earth, silica, vermulite, perlite, etc.
  • the aerosol type is a method of using an allergen inhibitor solution enclosed in a container together with a propellant in a compressed state, and spraying the allergen inhibitor in the form of a mist by the pressure of the propellant.
  • the propellant include nitrogen, carbon dioxide, dimethyl ether, and LPG.
  • the spray-type allergen inhibitors include oxygen supply agents (potassium perchlorate, potassium nitrate, potassium chlorate, etc.), combustion agents (sugars, starches, etc.), and exothermic regulators (guanidine nitrate, nitroguanidine, guanyl phosphate).
  • the allergen inhibitor can be smoked by adding an agent for decomposing oxygen (such as urea) and an auxiliary agent for decomposing oxygen supply agents (potassium chloride, copper oxide, chromium oxide, iron oxide, activated carbon, etc.).
  • the smoke type refers to a method of use in which an allergen inhibitor is finely divided into smoke and dispersed.
  • the matrix for mixing the allergen inhibitor is not particularly limited as long as it does not denature the allergen inhibitor.
  • examples include higher fatty acids, paraffins, liquid paraffins, white petrolatum, hydrocarbon gel ointment, polyethylene glycol, polyvinyl alcohol, sodium polyacrylate, and various paints.
  • an allergen inhibitory effect is imparted to the allergen object, and an allergen inhibitor product is obtained.
  • Allergens of the allergen object can be suppressed.
  • An “allergen object” refers to an object in which an allergen already exists, or an object in which no allergen currently exists but an allergen may exist in the future. Human bodies and animals are excluded from allergen objects.
  • the allergen is suppressed by supplying the allergen inhibitor. If the allergen is not present in the allergen object, the allergen inhibitor is applied to the allergen object in advance by providing the allergen inhibitor with an allergen inhibitory effect.
  • the allergen inhibitor may be used alone or in combination of two or more.
  • the allergen inhibitor is excellent in stability when a suspension is added to the above-mentioned allergen inhibitor solution to form a suspension. Spraying is preferred.
  • a method of chemically or physically fixing the allergen inhibitor to the allergen object a method of chemically bonding or physically fixing the allergen inhibitor described later to the fiber can be used.
  • examples of the allergen target include daily items that serve as a hotbed for allergens in a living space.
  • the allergen object is a fiber or a fiber product
  • the allergen inhibitor exhibits its effect more.
  • Living items include, for example, tatami mats, carpets, furniture (sofas, foam inside sofas, cloth chairs, tables, etc.), bedding (beds, futons, futon batting, duvet feathers, sheets, mattresses, cushions, etc.
  • Car interior items such as cars, airplanes, ships, and vehicle interior materials (seats, child seats and foams that make up these), kitchen items, baby items, architectural interior materials (Wallpaper, flooring, etc.), textile products (fabrics, curtains, towels, clothing, stuffed animals, etc.), textiles, filters such as screen doors, screen doors, and building interior materials.
  • the allergen inhibitor of the present invention since the allergen inhibitor of the present invention has almost no unexpected coloration or discoloration in the daily living environment, and there is almost no problem of color transfer, it can be applied to other products caused by light fading, discoloration, or rubbing. It is suitable for applications in which contamination due to color transfer is a problem, for example, textile products, building interior materials, vehicle interior products, vehicle interior materials, filters, and the like.
  • the above filter refers to a filter having the ability to separate, filter, and remove foreign substances.
  • a filter such as an air cleaner, an air conditioner, a vacuum cleaner, a ventilation fan, a mask that prevents entry of dust or pollen, a shoji, an insect, etc. And screen doors and kayaks that prevent entry.
  • the architectural interior material is not particularly limited, and examples thereof include floor materials, wallpaper, ceiling materials, paints, and waxes.
  • the fiber product is not particularly limited, and examples thereof include fabrics, bedding, carpets, curtains, towels, clothes, and stuffed animals.
  • the vehicle interior and vehicle interior materials are not particularly limited, and examples thereof include a seat, a child seat, a seat belt, a car mat, a seat cover, and a carpet.
  • the allergen inhibitory effect of the allergen inhibitor may not be manifested.
  • the allergen object may be damaged. Is preferably 0.001 to 100 parts by weight, more preferably 0.01 to 50 parts by weight, particularly preferably 0.02 to 30 parts by weight, and most preferably 0.02 to 20 parts by weight.
  • the allergens targeted by the allergen inhibitor of the present invention include leopard mite allergens (Der1, Der2), animal allergens such as dogs and cats (Can f1, Fel d1), and cedar pollen floating in the air. Examples include allergens (Cryj1, Cryj2) and plant allergens such as pollen. Animal allergens that are particularly effective include mite allergens (mites, arthropod ginsengs-mite organisms, which are mainly divided into seven subtypes.
  • Anterospira represented by ticks, mite, posterior genus represented by spider mite, middle antrum represented by house dust mite, spider mite, anterior genus represented by staghorn tick, nymph mite, leopard mites such as mite It can be a target for any type of anatomical gates such as Kenagakonadani, Jesa Saladani, and Hidden Gates represented by Kasari Mite, but it is often found in indoor dust, especially bedding, and causes allergic diseases. Is particularly effective.
  • the allergen inhibitor is supplied with an allergen inhibitor as necessary, thereby reacting the allergen object with a specific antibody that may or may be present in the allergen object in the future. Was to suppress.
  • the above-mentioned allergen inhibitor may be contained in a fiber to form an allergen-suppressing fiber, and the allergen suppressing effect may be imparted to the fiber itself.
  • the allergen-inhibiting effect can be imparted to the daily necessities in advance.
  • Examples of the method of incorporating the allergen inhibitor into the fiber include a method of chemically binding or physically fixing the allergen inhibitor to the fiber.
  • the fiber is not particularly limited as long as it can contain an allergen inhibitor.
  • a synthetic fiber such as a polyester fiber, a nylon fiber, an acrylic fiber, or a polyolefin fiber, or a half of an acetate fiber or the like.
  • synthetic fibers such as cupra and rayon, natural fibers such as cotton, hemp, wool, and silk, or composite fibers and mixed cottons of these various fibers.
  • the method for chemically binding the allergen inhibitor to the fiber includes a method of chemically binding the allergen inhibitor to the fiber by a grafting reaction.
  • the grafting reaction is not particularly limited.For example, (1) a graft polymerization method in which a polymerization initiation point is created in a trunk polymer to be a fiber, and an allergen inhibitor is polymerized as a branch polymer; (2) an allergen inhibitor is a polymer Examples thereof include a polymer reaction method in which the fiber is chemically bonded to the fiber by reaction.
  • Examples of the graft polymerization method include (1) a method in which a chain transfer reaction to a fiber is used to generate radicals and polymerize, and (2) a second cerium salt or silver sulfate salt such as alcohol, thiol, or amine. A method in which a reducing substance is allowed to act to form an oxidation-reduction system (redox system), and free radicals are generated in the fiber for polymerization. (3) A fiber and a monomer that is a raw material for the styrene polymer.
  • redox system oxidation-reduction system
  • a side chain active group such as hydroxyl, amino or carboxyl Examples thereof include a method using a polymerization initiation reaction of epoxy, lactam, polar vinyl monomer and the like.
  • graft polymerization methods are specifically listed. a) A method of carrying out graft polymerization by generating free radicals by grinding cellulose in a monomer that is a raw material of a styrenic polymer. b) A method of performing graft polymerization using a monomer as a raw material of a styrene polymer and a cellulose derivative (for example, mercaptoethyl cellulose) having a group that is susceptible to chain transfer as a fiber. c) A method in which graft polymerization is performed by oxidizing ozone and peroxide to generate radicals.
  • a method of carrying out graft polymerization by introducing a double bond such as allyl ether, vinyl ether or methacrylic acid ester into the side chain of cellulose e) A method of performing graft polymerization by irradiating a fiber with ultraviolet rays using sodium anthraquinone-2,7-disulfonate as a photosensitizer. f) A method of performing graft polymerization electrochemically by winding fibers around the cathode, adding a monomer as a raw material of the styrene polymer to dilute sulfuric acid, and applying an external voltage.
  • a fiber coated with glycidyl methacrylate (GMA) and benzoyl peroxide is graft polymerized by heating in a monomer solution that is a raw material for the styrenic polymer.
  • a surfactant nonionic surfactant or anionic surfactant
  • monochlorobenzene is dispersed in water, a monomer which is a raw material for the styrene polymer is added to the fiber.
  • a polyester fiber is immersed and heated to perform graft polymerization.
  • a general-purpose method can be used, for example, (1) chain transfer reaction, oxidation reaction, substitution reaction for C—H, (2) addition reaction for double bond, oxidation reaction, (3) Hydroxyl esterification, etherification, acetalization, substitution reaction for ester group and amide group, addition reaction, hydrolysis reaction, substitution reaction for halogen group, elimination reaction, (4) substitution reaction for aromatic ring (halogenation, nitro , Sulfonation, chloromethylation) and the like.
  • a method for physically fixing the allergen inhibitor to the fiber for example, (1) An allergen inhibitor solution is prepared by dissolving or dispersing the allergen inhibitor in a solvent, and the allergen inhibitor solution is impregnated with the fiber. A method of impregnating the fiber with an allergen inhibitor solution, (2) a method of applying the allergen inhibitor solution to the fiber surface, and (3) immersing the fiber in a binder obtained by dissolving or dispersing the allergen inhibitor.
  • the allergen inhibitor solution may contain the following binder.
  • the solvent is not particularly limited.
  • water alcohols such as methyl alcohol, ethyl alcohol, and propyl alcohol; hydrocarbons such as toluene, xylene, methylnaphthalene, kerosene, and cyclohexane; diethyl ether, tetrahydrofuran, dioxane, and the like Ethers; ketones such as acetone and methyl ethyl ketone; amides such as N, N-dimethylformamide and the like.
  • the binder is not particularly limited as long as it can fix the allergen inhibitor to the fiber surface.
  • the binder made of a synthetic resin may be a urethane resin such as a one-component urethane resin or a two-component urethane resin.
  • the allergen inhibitor is chemically bonded to a separately manufactured fiber, or physically fixed, so that the allergen inhibitor is contained in the fiber.
  • Fibers may be produced by spinning the combined fiber raw material.
  • the production method of the fiber raw material in which the allergen inhibitor is chemically bonded is not particularly limited.
  • the monomer having the structural formula represented by the general formula (1) and the monomer to be a general fiber raw material And a method of preparing a fiber raw material by copolymerizing such that the monomer having the structural formula represented by the general formula (1) is contained in an amount of 20 to 45% by weight.
  • the allergen inhibitor of the present invention contains a styrene polymer containing 20 to 45% by weight of the monomer component having the structural formula represented by the general formula (1), the allergen reacts with a specific antibody. Can be effectively suppressed, and allergic symptoms can be reduced or the occurrence thereof can be prevented. Furthermore, the allergen inhibitor of the present invention is less susceptible to unexpected discoloration or discoloration under daily use conditions, and can be suitably used for various daily necessities.
  • the allergen inhibitor of the present invention can be applied to an allergen object to impart an excellent allergen inhibitory effect to the allergen object. Even if the allergen object is a fiber product or a fiber such as a fabric colored with a pigment such as a pigment or a dye, the allergen object treated with the allergen inhibitor is rubbed with the other product to give a color to the other product. There is no transfer. Therefore, it is possible to prevent the color fading of the allergen object due to the color transfer to another product and the contamination of the other product due to the color transfer from the allergen object.
  • Example 1 A 2-liter separable flask equipped with a stirrer, a cooler and a thermometer, 67 parts by weight of sodium p-styrenesulfonate (trade name “Spinomer NaSS” manufactured by Tosoh Corporation, purity: 88.2% by weight), deionized 312 parts by weight of water, 135 parts by weight of styrene monomer (trade name “styrene, monomer” manufactured by Wako Pure Chemical Industries, Ltd.) and 407 parts by weight of modified ethanol (trade name “86% ethanol-ME, modified” manufactured by Wako Pure Chemical Industries, Ltd.) were added. The mixture was replaced with nitrogen gas while stirring, and then heated and maintained at 78 ° C.
  • spinomer NaSS sodium p-styrenesulfonate
  • deionized 312 parts by weight of water 135 parts by weight of styrene monomer (trade name “styrene, monomer” manufactured by Wako Pure Chemical Industries
  • a polymerization initiator solution prepared by dissolving 4.4 parts by weight of potassium peroxodisulfate (manufactured by Wako Pure Chemical Industries, Ltd.) in 95 parts by weight of deionized water was added to the separable flask over 15 minutes, and then over 5 hours. Styrene monomer and sodium p-styrene sulfonate were polymerized.
  • reaction solution was dried to obtain a polymer.
  • 50 parts by weight of the obtained polymer was dispersed in 500 parts by weight of ion-exchanged water to prepare a dispersion, and sodium hydroxide was added so that the pH of the dispersion became 8.5 while stirring the dispersion with a stirrer.
  • the polymer was separated from the dispersion, filtered and dried to obtain a p-sodium styrenesulfonate-styrene random copolymer.
  • the sodium p-styrenesulfonate component was 30.4% by weight and the styrene component was 69.6% by weight.
  • the weight average molecular weight of the p-sodium styrenesulfonate-styrene random copolymer was 90,000.
  • the average particle size of the p-sodium styrenesulfonate-styrene random copolymer was 2 ⁇ m.
  • black fabric A plain twill fabric (cotton 100% by weight)
  • black fabric B T / C broad fabric (polyester: 65% by weight, cotton: 35% by weight)
  • Example 2 In the same manner as in Example 1, except that sodium p-styrenesulfonate was changed to 93.2 parts by weight, styrene monomer to 110 parts by weight, and potassium peroxodisulfate to 4.05 parts by weight, p-styrene was used. A sodium sulfonate-styrene random copolymer was obtained. In the p-sodium styrenesulfonate-styrene random copolymer, the sodium p-styrenesulfonate component was 42.8% by weight and the styrene component was 57.2% by weight.
  • the weight average molecular weight of the p-sodium styrenesulfonate-styrene random copolymer was 80,000.
  • the average particle size of the p-sodium styrenesulfonate-styrene random copolymer was 1 ⁇ m.
  • Test piece A in the same manner as in Example 1 to obtain a B.
  • Example 3 95.2 parts by weight of ammonium p-styrene sulfonate was used instead of sodium p-styrene sulfonate, styrene monomer was changed to 50 parts by weight, and potassium peroxodisulfate was changed to 4.05 parts by weight.
  • a p-styrene sulfonic acid ammonium-styrene random copolymer was obtained in the same manner as in Example 1 except that 25 wt% aqueous ammonia was used instead of sodium hydroxide for pH adjustment. .
  • the ammonium p-styrene ammonium sulfonate-styrene random copolymer was 43.2% by weight and the styrene component was 56.8% by weight.
  • the weight average molecular weight of the p-ammonium styrenesulfonate-styrene random copolymer was 90,000.
  • the average particle size of the p-ammonium styrenesulfonate-styrene random copolymer was 2 ⁇ m.
  • Specimens A and B were obtained in the same manner as in Example 1, except that p-ammonium styrenesulfonate-styrene random copolymer was used instead of p-sodium styrenesulfonate-styrene random copolymer.
  • Example 4 50 parts by weight of the polymer before pH adjustment obtained in the same manner as in Example 1 was dispersed in 500 parts by weight of ion-exchanged water to prepare a dispersion, and this dispersion was stirred with a stirrer to adjust the pH of the dispersion. Hydrochloric acid was added to the dispersion so as to be 5.5, and the dispersion was stirred for 5 hours, and then the polymer was separated from the dispersion, filtered, and dried to obtain p-sodium styrenesulfonate-p- A styrene sulfonic acid-styrene random copolymer was obtained.
  • the sodium p-styrenesulfonate component was 27.7% by weight
  • the p-styrenesulfonate component was 2.7% by weight
  • styrene The component was 69.6% by weight.
  • the weight average molecular weight of p-sodium styrenesulfonate-p-styrenesulfonate-styrene random copolymer was 90,000.
  • the average particle size of the p-sodium styrenesulfonate-p-styrenesulfonate-styrene random copolymer was 2 ⁇ m.
  • Specimen A in the same manner as in Example 1 except that p-sodium styrenesulfonate-p-styrenesulfonic acid-styrene random copolymer was used instead of p-sodium styrenesulfonate-styrene random copolymer. , B was obtained.
  • the total content of sodium p-styrene sulfonate and p-styrene sulfonic acid in the p-sodium styrene sulfonate-p-styrene sulfonate-styrene random copolymer is shown in Table 1 “Content of p-styrene sulfonate component”. For convenience, it is shown in the column “Amount”.
  • Example 1 In the same manner as in Example 1, except that sodium p-styrenesulfonate was changed to 37 parts by weight, the styrene monomer was changed to 155 parts by weight, and potassium peroxodisulfate was changed to 4.5 parts by weight, p-styrenesulfonic acid was used. A sodium-styrene random copolymer was obtained. In the p-sodium styrenesulfonate-styrene random copolymer, the p-sodium styrenesulfonate component was 17.4% by weight and the styrene component was 82.6% by weight.
  • the weight average molecular weight of the p-sodium styrenesulfonate-styrene random copolymer was 80,000.
  • the average particle size of the p-sodium styrenesulfonate-styrene random copolymer was 3 ⁇ m.
  • Test piece A in the same manner as in Example 1 to obtain a B.
  • Example 2 Sodium p-styrenesulfonate in the same manner as in Example 1 except that sodium p-styrenesulfonate was changed to 100 parts by weight, styrene was changed to 93 parts by weight, and potassium peroxodisulfate was changed to 3.73 parts by weight. -A styrene random copolymer was obtained. In the p-sodium styrenesulfonate-styrene random copolymer, the sodium p-styrenesulfonate component was 48.6% by weight and the styrene component was 51.4% by weight.
  • the weight average molecular weight of the p-sodium styrenesulfonate-styrene random copolymer was 100,000.
  • the average particle size of the p-sodium styrenesulfonate-styrene random copolymer was 1 ⁇ m.
  • Test piece A in the same manner as in Example 1 to obtain a B.
  • test pieces A and B obtained in the examples and comparative examples were measured for the allergen suppressing effect and color transferability in the following manner, and the results are shown in Table 1.
  • An allergen chilled dry powder (trade name “MiteExtract-Df” manufactured by Cosmo Bio Inc.) was dissolved in a phosphate buffer (pH 7.6) to prepare an allergen aqueous solution having a protein amount of 20 ⁇ g / ml.
  • Evaluation samples A and B each having a rectangular shape of 1 cm in length and 5 cm in width were cut out from each of the test pieces A and B obtained in Examples and Comparative Examples.
  • the allergen measuring device (trade name “Mighty Checker” manufactured by Sumika Enviro Science Co., Ltd.)
  • the initial allergen inhibitory effect was evaluated. The darker the color of the allergen measuring device, the more allergen is present in the liquid.
  • the following 1 to 3 determination was set as the pass. 5 ... A thick, thick and clear line was observed. 4 ... It can be clearly seen that it is a line. It is coloring faintly in 3 ... line shape. 2 ... The color is faintly colored. 1 ... No color development at all.
  • Evaluation samples A and B were prepared in the same manner as the evaluation of the initial allergen inhibitory effect. Each of these evaluation samples A and B was separately immersed in 200 ml of water kept at 25 ° C. for 1 minute and taken out, and each of the evaluation samples A and B was dried at 100 ° C. for 10 minutes. did. For the evaluation sample pieces A and B, the allergen suppressing effect was measured in the same manner as described above.
  • the allergen inhibitor of the present invention has an excellent allergen suppressing effect, is unlikely to cause unexpected discoloration, and hardly causes color transfer. Therefore, the allergen inhibitor of the present invention can easily give an allergen inhibitory effect to an allergen object such as daily necessities. Furthermore, since the allergen inhibitor of the present invention has almost no unexpected coloration or discoloration in the daily living environment, and there is almost no problem of color transfer, it can be used for other products caused by light fading, discoloration, or rubbing. It can be suitably used for applications in which contamination due to color transfer is a problem, such as textile products, building interior materials, in-car accessories, vehicle interior materials, and filters.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Textile Engineering (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Polymers & Plastics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)

Abstract

The present invention provides an allergen inhibitor that: effectively prevents allergens from reacting with specific antibodies, enabling allergy symptoms to be mitigated or the manifestation of said allergy symptoms to be prevented; and is less likely to undergo unpredictable discoloration and discoloration under conditions of everyday use, and is not prone to color transfer. This allergen inhibitor is characterized by containing a styrene-based polymer containing 20 to 45 wt% of a monomeric component with a structural formula represented by general formula (1), and therefore exhibits the excellent effects of: effectively preventing allergens from reacting with specific antibodies, enabling allergy symptoms to be mitigated or the manifestation of said allergy symptoms to be prevented; and being less likely to undergo unpredictable discoloration and discoloration under conditions of everyday use, and not being prone to color transfer.

Description

アレルゲン抑制剤、アレルゲン抑制製品、アレルゲンの抑制方法及びアレルゲン抑制剤としての使用Allergen inhibitor, allergen inhibitor product, allergen suppression method and use as allergen inhibitor
 本発明は、スギなどの草木の花粉、ダニ、室内の塵などのアレルゲンが特異抗体と反応するのを抑制することができ且つ不測の変色や日常の使用条件下での変色が生じ難く、更に、色移りの生じ難いアレルゲン抑制剤、及び、このアレルゲン抑制剤をアレルゲン対象物に処理して得られるアレルゲン抑制製品に関する。 The present invention can suppress the reaction of allergens such as pollen of vegetation such as cedar, mites, and indoor dust with specific antibodies, and is unlikely to cause unexpected discoloration or discoloration under daily use conditions. The present invention relates to an allergen inhibitor that hardly causes color transfer, and an allergen-suppressed product obtained by treating the allergen inhibitor with an allergen object.
 近年、アトピー性皮膚炎、気管支喘息、アレルギー性鼻炎などの多くのアレルギー疾患が問題となってきている。このアレルギー疾患の主な原因としては、住居内に生息するダニ類、特に、室内塵中に多く存在するヒョウヒダニのアレルゲン(Der1、Der2)や、主に春季に多量に空気中に浮遊するスギ花粉アレルゲン(Cry j1、Cry j2)などのアレルゲンが生活空間内に増加してきているためである。 In recent years, many allergic diseases such as atopic dermatitis, bronchial asthma and allergic rhinitis have become a problem. The main causes of this allergic disease are mites living in the house, especially leopard mite allergens (Der1, Der2), which are abundant in indoor dust, and cedar pollen floating in the air mainly in spring. This is because allergens such as allergens (Cry j1, Cry j2) are increasing in the living space.
 ヒョウヒダニのアレルゲンは、ヒョウヒダニそのものではなく、ヒョウヒダニの死骸や糞がアレルゲンとなるために、ヒョウヒダニを駆除しても、アレルギー疾患の根本的な解決にはならない。 ア Leopard mite allergens are not leopard mites themselves, but the dead bodies and feces of leopard mites become allergens, so even if you remove the leopard mites, it will not be a fundamental solution to allergic diseases.
 又、スギ花粉アレルゲンであるCry j1やCry j2は、各々分子量が約40kDaの糖タンパク質、分子量が約37kDaの糖タンパク質であり、これらのスギ花粉アレルゲンは、鼻粘膜などに付着すると生体外異物として認識されて炎症反応を引き起こす。 The cedar pollen allergens Cry j1 and Cry j2 are glycoproteins having a molecular weight of about 40 kDa and a molecular weight of about 37 kDa, respectively. These cedar pollen allergens are in vitro as foreign substances when attached to the nasal mucosa. It is recognized and causes an inflammatory response.
 従って、アレルギー疾患の症状を軽減し或いは新たなアレルギー症状を防止するためには、生活空間からアレルゲンを完全に取り除くか、アレルゲンを変性させるなどして不活性化させることが必要となる。 Therefore, in order to reduce the symptoms of allergic diseases or prevent new allergic symptoms, it is necessary to completely remove allergens from the living space or to inactivate allergens.
 アレルゲンは蛋白質であるので、アレルゲンを熱、強酸又は強アルカリなどで変性させると、アレルゲンはアレルゲン性を失うと考えられる。しかしながら、アレルゲンは非常に安定性が高く、家庭で安全に使用できる酸化剤、還元剤、熱、アルカリ、酸などでは容易に変性されない(非特許文献1参照)。 Since allergen is a protein, it is considered that allergen loses allergenicity when it is denatured with heat, strong acid or strong alkali. However, allergens are very stable and are not easily denatured by oxidizing agents, reducing agents, heat, alkalis, acids, etc. that can be used safely at home (see Non-Patent Document 1).
 又、アレルゲンに汚染された対象物に存在するアレルゲンを変性させようとすると、アレルゲンの汚染場所である対象物、例えば、畳、絨毯、床、家具(ソファー、布ばり椅子、テーブル)、寝具(ベッド、布団、シーツ)、車輛内用品(シート、チャイルドシート)、車輛内装材(天井材など)、キッチン用品、ベビー用品、カーテン、壁紙、タオル、衣類、ぬいぐるみ、その他の繊維製品、空気清浄機(本体及びフィルター)などが条件によっては破損してしまう可能性があった。 Further, when allergens present in an object that is contaminated with allergens are to be denatured, the objects that are contaminated with allergens, such as tatami mats, carpets, floors, furniture (sofas, cloth chairs, tables), bedding ( Beds, futons, sheets), interior items (seats, child seats), vehicle interior materials (ceiling materials, etc.), kitchen items, baby items, curtains, wallpaper, towels, clothing, stuffed animals, other textile products, air purifiers ( The main body and filter) may be damaged depending on conditions.
 このため、アレルゲンの分子表面を比較的温和な条件で化学的に変性する方法が考えられてきた。例えば、生皮のなめし(タンニング)などに用いられているタンニン酸を用いてアレルゲンを抑制する方法(特許文献1)、茶抽出物などを用いてアレルゲンを抑制する方法(特許文献2)などが提案され、アレルゲン抑制効果も確認されている。 For this reason, a method has been considered in which the molecular surface of the allergen is chemically denatured under relatively mild conditions. For example, a method for suppressing allergen using tannic acid used for tanning of rawhide (Patent Document 1), a method for suppressing allergen using tea extract or the like (Patent Document 2), etc. are proposed. In addition, the allergen suppressing effect has been confirmed.
 しかしながら、これらの方法で用いられる化合物のほとんどはポリフェノールの一種であることから着色しており、上記対象物を着色してしまうといった問題点があった。 However, most of the compounds used in these methods are colored because they are a kind of polyphenol, which causes the problem of coloring the object.
 特許文献3には、芳香族ヒドロキシ化合物を有効成分とするアレルゲン抑制剤が提案されており、対象物に対する着色の問題については改善されているが、白色などの淡色の対象物に処理した場合には着色が生じることがあり充分なものではなかった。 Patent Document 3 proposes an allergen inhibitor containing an aromatic hydroxy compound as an active ingredient, which has improved the problem of coloring the object, but when processed into a light-colored object such as white. Coloration may occur and was not sufficient.
 特許文献4には、アレルゲン抑制化合物を含有するアレルゲン抑制剤であって、上記アレルゲン抑制化合物がp-スチレンスルホン酸単独重合体のスルホン酸ナトリウム塩であるアレルゲン抑制剤が提案されているが、日常生活において水と接する機会の多い製品、例えば、衣料などの繊維製品などに応用された場合、耐久性が悪くなるという問題点がある。 Patent Document 4 proposes an allergen inhibitor containing an allergen inhibitor compound, in which the allergen inhibitor compound is a sodium sulfonate salt of a p-styrenesulfonic acid homopolymer. When applied to products that have many opportunities to come into contact with water in daily life, for example, textile products such as clothing, there is a problem that durability deteriorates.
 特許文献5には、スチレンスルホン酸単位を有する高分子化合物からなるアレルゲン不活性剤が提案され、具体的には、実施例において、スチレンスルホン酸比率が50~70重量%である高分子化合物のみがアレルゲン不活性剤として用いられ、不活性化効果が測定されているものの、スチレンスルホン酸比率が50~70重量%以外の高分子化合物については不活性化効果が測定されていない。 Patent Document 5 proposes an allergen deactivator comprising a polymer compound having a styrene sulfonic acid unit. Specifically, in the examples, only the polymer compound having a styrene sulfonic acid ratio of 50 to 70% by weight is proposed. Is used as an allergen deactivator and its inactivation effect has been measured, but the deactivation effect has not been measured for polymer compounds having a styrenesulfonic acid ratio other than 50 to 70% by weight.
 更に、高分子化合物中においてスチレンスルホン酸比率が50~70重量%であると、アレルゲン不活性剤を例えば、衣料などの繊維製品などに処理した場合、アレルゲン不活性剤が原因となって、繊維製品の色が他の製品に移ってしまい、他の製品を汚染するという問題点を有している。 Furthermore, when the styrene sulfonic acid ratio in the polymer compound is 50 to 70% by weight, when the allergen inactive agent is processed into, for example, a textile product such as clothing, the allergen inactive agent causes the fiber. There is a problem that the color of the product is transferred to another product and contaminates the other product.
特開昭61-44821号公報JP 61-44821 A 特開平6-279273号公報JP-A-6-279273 特開2003-81727号公報JP 2003-81727 A 特許第4619452号Japanese Patent No. 4619452 特開2009-155453号公報JP 2009-155453 A
 本発明は、アレルゲンが特異抗体と反応するのを効果的に抑制し、アレルギー症状の軽減或いはその発現の予防をすることができると共に、不測の変色、日常の使用条件下での変色が生じにくく、更に、色移りの生じ難いアレルゲン抑制剤、及び、このアレルゲン抑制剤をアレルゲン対象物に処理して得られるアレルゲン抑制製品を提供する。 The present invention effectively suppresses allergens from reacting with specific antibodies, can reduce allergy symptoms or prevent their occurrence, and is unlikely to cause unexpected discoloration or discoloration under daily use conditions. Furthermore, the present invention provides an allergen inhibitor that hardly causes color transfer, and an allergen-suppressed product obtained by treating the allergen inhibitor with an allergen object.
 本発明のアレルゲン抑制剤は、一般式(1)で示される構造式の単量体成分を20~45重量%含有するスチレン系重合体を有効成分として含有している。 The allergen inhibitor of the present invention contains a styrene polymer containing 20 to 45% by weight of a monomer component having the structural formula represented by the general formula (1) as an active ingredient.
Figure JPOXMLDOC01-appb-C000005

(R1~R5はそれぞれ、水素、スルホン酸基又はスルホン酸基の塩の何れかであって、R1~R5のうちの少なくとも一つは、スルホン酸基又はスルホン酸基の塩である。)
Figure JPOXMLDOC01-appb-C000005

(R 1 to R 5 are each hydrogen, a sulfonic acid group or a sulfonic acid group salt, and at least one of R 1 to R 5 is a sulfonic acid group or a sulfonic acid group salt. is there.)
 ここで、アレルゲン抑制剤とは、アレルゲン抑制効果を有するものをいい、又、「アレルゲン抑制効果」とは、ヒョウヒダニのアレルゲン(Der1、Der2)、空気中に浮遊するスギ花粉アレルゲン(Cryj1、Cryj2)、犬や猫に起因するアレルゲン(Can f1、Fel d1)などのアレルゲンを変性し或いは吸着し、アレルゲンの特異抗体に対する反応性を抑制する効果をいう。このようなアレルゲン抑制効果を確認する方法としては、例えば、ニチニチ製薬社から市販されているELISAキットを用いてELISA法によりアレルゲン量を測定する方法、アレルゲン測定具(住化エンビロサイエンス社製 商品名「マイティーチェッカー」)を用いてアレルゲン性を評価する方法などが挙げられる。 Here, the allergen inhibitor refers to those having an allergen inhibitory effect, and the “allergen inhibitory effect” refers to leopard mite allergens (Der1, Der2), cedar pollen allergens (Cryj1, Cryj2) floating in the air The allergens such as allergens (Can f1, Fel d1) caused by dogs and cats are denatured or adsorbed to suppress the reactivity of allergens to specific antibodies. As a method for confirming such an allergen inhibitory effect, for example, a method for measuring the amount of allergen by ELISA using an ELISA kit commercially available from Nitinichi Pharmaceutical Co., Ltd., an allergen measuring instrument (commercially available from Sumika Enviro Science Co., Ltd.) And a method for evaluating allergenicity using the name “Mighty Checker”).
 一般式(1)で示される構造式の単量体成分を20~45重量%含有するスチレン系重合体の製造方法は、例えば、(1)一般式(1)で示される構造式の単量体と、この単量体と重合可能な他の単量体とを共重合させる方法、(2)ポリスチレンのベンゼン環の一部をスルホン化する方法、(3)ポリスチレンのベンゼン環の一部をスルホン化し、導入したスルホン酸基(-SO3H)をアルカリ水溶液で中和してスルホン酸基を塩とする方法、(4)一般式(1)で示される構造式の単量体と、この単量体と重合可能な他の単量体との共重合のベンゼン環の一部をスルホン化し、導入したスルホン酸基(-SO3H)をアルカリ水溶液で中和してスルホン酸基を塩とする方法、(5)ポリスチレンスルホン酸、スチレンスルホン酸とこれと共重合可能な他の単量体との共重合体又はこれらのスルホン酸の塩において、スルホン酸基の一部を脱スルホンする方法などが挙げられる。なお、アルカリ水溶液としては、例えば、水酸化ナトリウム、水酸化カリウム、水酸化マグネシウム、水酸化アンモニウムなどが挙げられる。 A method for producing a styrenic polymer containing 20 to 45% by weight of the monomer component having the structural formula represented by the general formula (1) is, for example, (1) a single unit of the structural formula represented by the general formula (1). A copolymer of this monomer with another monomer that can be polymerized, (2) a method of sulfonating a part of the benzene ring of polystyrene, and (3) a part of the benzene ring of polystyrene. Sulfonated and introduced sulfonic acid group (—SO 3 H) is neutralized with an aqueous alkaline solution to form a sulfonic acid group as a salt; (4) a monomer having the structural formula represented by the general formula (1); A part of the benzene ring in the copolymerization of this monomer with another polymerizable monomer is sulfonated, and the introduced sulfonic acid group (—SO 3 H) is neutralized with an alkaline aqueous solution to remove the sulfonic acid group. (5) polystyrene sulfonic acid, styrene sulfonic acid and this In the copolymer, or salts of these sulfonic acids with other copolymerizable monomers, a method of desulfonation part of the sulfonic acid group. Examples of the alkaline aqueous solution include sodium hydroxide, potassium hydroxide, magnesium hydroxide, and ammonium hydroxide.
 一般式(1)において、R1~R5はそれぞれ、水素(-H)、スルホン酸基(-SO3H)又はスルホン酸基の塩の何れかであるが、R1~R5のうちの少なくとも一つは、スルホン酸基又はスルホン酸基の塩であることが必要である。これは、一般式(1)において、置換基としてスルホン酸基又はスルホン酸基の塩を有していないと、アレルゲン抑制剤がアレルゲン抑制効果を発現しないからである。スルホン酸基の塩としては、例えば、-SO3Na、-SO3K、-SO3Li、(-SO32Ca、(-SO32Mg、-SO3 NH4 +が挙げられ、スルホン酸基の塩の自由度が高くてアレルゲンの変性効果又は吸着効果が高く、アレルゲン抑制剤のアレルゲン抑制効果が高いので、スルホン酸基の一価の塩が好ましく、-SO3Na、-SO3K、-SO3Li、-SO3 NH4 +がより好ましく、-SO3Na、-SO3 NH4 +が特に好ましい。なお、上記スルホン酸基の一価の塩は、-SO3Mで表され、Mは、一価の陽イオンである。Mとしては、例えば、Na+、K+、Li+、NH4 +などが挙げられる。 In the general formula (1), R 1 to R 5 are each hydrogen (—H), a sulfonic acid group (—SO 3 H), or a salt of a sulfonic acid group, of R 1 to R 5 It is necessary that at least one of these is a sulfonic acid group or a salt of a sulfonic acid group. This is because in the general formula (1), the allergen inhibitor does not exhibit an allergen inhibitory effect unless it has a sulfonic acid group or a salt of a sulfonic acid group as a substituent. The salt of a sulfonic acid group, for example, -SO 3 Na, -SO 3 K , -SO 3 Li, (- SO 3) 2 Ca, (- SO 3) 2 Mg, -SO 3 - NH 4 + can be mentioned In addition, the monovalent salt of a sulfonic acid group is preferred because the degree of freedom of the salt of the sulfonic acid group is high, the allergen denaturing effect or adsorption effect is high, and the allergen inhibitory effect of the allergen inhibitor is high, and —SO 3 Na, -SO 3 K, -SO 3 Li, -SO 3 - NH 4 + are more preferable, -SO 3 Na, -SO 3 - NH 4 + is particularly preferred. The monovalent salt of the sulfonic acid group is represented by —SO 3 M, and M is a monovalent cation. Examples of M include Na + , K + , Li + , NH 4 + and the like.
 そして、一般式(1)において、スルホン酸基及びスルホン酸基の塩の総数は、多いと、アレルゲン抑制効果がなくなるので、1~3が好ましく、1がより好ましい。 In the general formula (1), if the total number of sulfonic acid groups and sulfonic acid group salts is large, the allergen suppressing effect is lost, and therefore, 1 to 3 is preferable, and 1 is more preferable.
 又、一般式(1)において、立体障害が少ないことから、R3が、スルホン酸基又はスルホン酸基の塩であると共に、R1、R2、R4及びR5が水素であることが好ましい。 In the general formula (1), since steric hindrance is small, R 3 is a sulfonic acid group or a salt of a sulfonic acid group, and R 1 , R 2 , R 4 and R 5 are hydrogen. preferable.
 一般式(1)で示される構造式の単量体としては、例えば、o-スチレンスルホン酸、o-スチレンスルホン酸ナトリウム、m-スチレンスルホン酸、m-スチレンスルホン酸ナトリウム、p-スチレンスルホン酸、p-スチレンスルホン酸ナトリウム、スチレンスルホン酸カルシウム、スチレンスルホン酸カルシウム、o-スチレンスルホン酸カリウム、m-スチレンスルホン酸カリウム、p-スチレンスルホン酸カリウム、o-スチレンスルホン酸リチウム、m-スチレンスルホン酸リチウム、p-スチレンスルホン酸リチウム、o-スチレンスルホン酸アンモニウム、m-スチレンスルホン酸アンモニウム、p-スチレンスルホン酸アンモニウム、スチレンスルホン酸マグネシウムなどが挙げられ、スチレンスルホン酸の一価の塩が好ましく、スチレンスルホン酸ナトリウム、スチレンスルホン酸カリウム、スチレンスルホン酸リチウム、スチレンスルホン酸アンモニウムがより好ましく、p-スチレンスルホン酸ナトリウムが特に好ましい。 Examples of the monomer represented by the general formula (1) include o-styrene sulfonic acid, o-sodium styrene sulfonate, m-styrene sulfonic acid, sodium m-styrene sulfonate, and p-styrene sulfonic acid. P-sodium styrenesulfonate, calcium styrenesulfonate, calcium styrenesulfonate, potassium o-styrenesulfonate, potassium m-styrenesulfonate, potassium p-styrenesulfonate, lithium o-styrenesulfonate, m-styrenesulfone Lithium sulfonate, lithium p-styrene sulfonate, ammonium o-styrene sulfonate, ammonium m-styrene sulfonate, ammonium p-styrene sulfonate, magnesium styrene sulfonate, etc. Preferred, sodium styrene sulfonate, potassium styrene sulfonate, lithium styrene sulfonate, ammonium styrene sulfonate is more preferred, sodium p- styrenesulfonate are particularly preferable.
 スチレン系重合体中において、一般式(1)で示される構造式の単量体成分以外の単量体成分としては、例えば、メチルアクリレート、エチルアクリレート、2-ヒドロキシエチルアクリレートなどのアルキルアクリレート、メチルメタクリレート、エチルメタクリレート、2-ヒドロキシエチルメタクリレートなどアルキルメタクリレート、ビニルメチルエーテルなどのビニルアルキルエーテル、酢酸ビニル、エチレン、プロピレン、ブチレン、ブタジエン、ジイソブチレン、塩化ビニル、塩化ビニリデン、2-ビニルナフタレン、スチレン、アクリロニトリル、アクリル酸、アクリル酸ナトリウム、メタクリル酸、メタクリル酸ナトリウム、マレイン酸、フマル酸、無水マレイン酸、アクリルアミド、メタクリルアミド、ジアセトンアクリルアミド、ビニルトルエン、キシレンスルホン酸、ビニルピリジン、ビニルスルホン酸、ビニルアルコール、ヒドロキシエチルメタクリレート、ヒドロキシエチルアクリレートなどが挙げられ、アレルゲン抑制剤の耐久性の向上及び高いアレルゲン抑制効果を発揮するという点からスチレンが好ましい。 Examples of the monomer component other than the monomer component of the structural formula represented by the general formula (1) in the styrenic polymer include alkyl acrylates such as methyl acrylate, ethyl acrylate and 2-hydroxyethyl acrylate, methyl Methacrylate, ethyl methacrylate, alkyl methacrylate such as 2-hydroxyethyl methacrylate, vinyl alkyl ether such as vinyl methyl ether, vinyl acetate, ethylene, propylene, butylene, butadiene, diisobutylene, vinyl chloride, vinylidene chloride, 2-vinylnaphthalene, styrene, Acrylonitrile, acrylic acid, sodium acrylate, methacrylic acid, sodium methacrylate, maleic acid, fumaric acid, maleic anhydride, acrylamide, methacrylamide, diacetone Rylamide, vinyltoluene, xylene sulfonic acid, vinyl pyridine, vinyl sulfonic acid, vinyl alcohol, hydroxyethyl methacrylate, hydroxyethyl acrylate, etc. are mentioned, from the point of improving durability of allergen inhibitor and exhibiting high allergen inhibitory effect Styrene is preferred.
 スチレン系重合体は、主鎖の自由度が高く、アレルゲンの変性効果又は吸着効果が高いので、直鎖状であることが好ましい。 Styrenic polymers are preferably linear because they have a high degree of freedom in the main chain and a high allergen-modifying or adsorbing effect.
 アレルゲン抑制剤のスチレン系重合体中において、一般式(1)で示される構造式の単量体成分の含有量は、少ないと、アレルゲン抑制剤のアレルゲン抑制効果が低下する。アレルゲン抑制剤のスチレン系重合体中において、一般式(1)で示される構造式の単量体成分の含有量は、多いと、アレルゲン抑制剤が顔料や染料などの色素と馴染みやすくなって色素が脱落し易くなる。その結果、例えば、黒色などの濃色の繊維にアレルゲン抑制剤を処理した場合、繊維が他の製品と日常生活において擦れることにより、繊維の濃色が他の製品に移り、他の製品を汚染する。従って、アレルゲン抑制剤のスチレン系重合体中において、一般式(1)で示される構造式の単量体成分の含有量は、20~45重量%に限定され、25~45重量%が好ましい。 If the content of the monomer component of the structural formula represented by the general formula (1) is small in the styrene polymer of the allergen inhibitor, the allergen inhibitory effect of the allergen inhibitor is lowered. In the styrene polymer of the allergen inhibitor, if the content of the monomer component of the structural formula represented by the general formula (1) is large, the allergen inhibitor becomes easily compatible with pigments such as pigments and dyes. Is easy to drop off. As a result, for example, when dark fibers such as black are treated with an allergen inhibitor, the fibers will rub against other products in daily life, causing the dark color of the fibers to move to other products and contaminating other products. To do. Therefore, the content of the monomer component of the structural formula represented by the general formula (1) in the styrene polymer of the allergen inhibitor is limited to 20 to 45% by weight, and preferably 25 to 45% by weight.
 一般式(1)で示される構造式の単量体成分を含有するスチレン系重合体としては、例えば、p-スチレンスルホン酸塩-スチレン共重合体、o-スチレンスルホン酸塩-スチレン共重合体、m-スチレンスルホン酸塩-スチレン共重合体などのスチレンスルホン酸塩-スチレン共重合体、スチレンスルホン酸塩-スチレンスルホン酸-スチレン三元共重合体、p-スチレンスルホン酸又はその塩のうちの少なくとも一つの単量体とマレイン酸との共重合体、p-スチレンスルホン酸又はその塩のうちの少なくとも一つの単量体と2-ヒドロキシエチルメタクリレートとの共重合体、p-スチレンスルホン酸又はその塩のうちの少なくとも一つの単量体とアクリル酸との共重合体、p-スチレンスルホン酸又はその塩のうちの少なくとも一つの単量体とメタクリル酸との共重合体、p-スチレンスルホン酸又はその塩のうちの少なくとも一つの単量体とメチルメタクリレートとの共重合体、ポリスチレンのスルホン化体、スチレン-マレイン酸共重合体をそのベンゼン環においてスルホン化した重合体のスルホン酸基の一部又は全てを塩とした重合体などが挙げられるが、アレルゲン抑制剤の耐久性が向上し、且つ、アレルゲン抑制剤が高いアレルゲン抑制効果を奏することから、スチレンスルホン酸塩-スチレン共重合体、スチレンスルホン酸塩-スチレンスルホン酸-スチレン三元共重合体及びポリスチレンのスルホン化体からなる群から選ばれた少なくとも一種の重合体であることが好ましい。なお、上記スチレン系重合体は、単独で用いられても二種以上が併用されてもよい。 Examples of the styrene polymer containing the monomer component having the structural formula represented by the general formula (1) include p-styrene sulfonate-styrene copolymer and o-styrene sulfonate-styrene copolymer. Styrene sulfonate-styrene copolymer such as m-styrene sulfonate-styrene copolymer, styrene sulfonate-styrene sulfonic acid-styrene terpolymer, p-styrene sulfonic acid or a salt thereof A copolymer of at least one monomer and maleic acid, a copolymer of at least one monomer of p-styrenesulfonic acid or a salt thereof and 2-hydroxyethyl methacrylate, p-styrenesulfonic acid Or a copolymer of at least one monomer of its salt and acrylic acid, at least one of p-styrenesulfonic acid or its salt Copolymer of methacrylic acid monomer, copolymer of at least one monomer of p-styrene sulfonic acid or its salt and methyl methacrylate, sulfonated polystyrene, styrene-maleic acid copolymer Examples include polymers in which some or all of the sulfonic acid groups of the polymer sulfonated on the benzene ring are salts, but the durability of the allergen inhibitor is improved and the allergen inhibitor is high. Because of its allergen-inhibiting effect, at least one heavy selected from the group consisting of a styrene sulfonate-styrene copolymer, a styrene sulfonate-styrene sulfonic acid-styrene terpolymer, and a polystyrene sulfonate. It is preferably a coalescence. In addition, the said styrenic polymer may be used independently, or 2 or more types may be used together.
 スチレンスルホン酸塩-スチレン共重合体としては、特に限定されず、例えば、スチレンスルホン酸ナトリウム-スチレン共重合体、スチレンスルホン酸カリウム-スチレン共重合体、スチレンスルホン酸リチウム-スチレン共重合体、スチレンスルホン酸カルシウム-スチレン共重合体、スチレンスルホン酸アンモニウム-スチレン共重合体、スチレンスルホン酸マグネシウム-スチレン共重合体などが挙げられ、スチレンスルホン酸カリウム-スチレン共重合体、スチレンスルホン酸リチウム-スチレン共重合体、スチレンスルホン酸アンモニウム-スチレン共重合体、スチレンスルホン酸ナトリウム-スチレン共重合体が好ましく、p-スチレンスルホン酸ナトリウム-スチレン共重合体がより好ましい。なお、スチレンスルホン酸塩-スチレン共重合体は、単独で用いられても二種以上が併用されてもよい。 The styrene sulfonate-styrene copolymer is not particularly limited. For example, sodium styrene sulfonate-styrene copolymer, potassium styrene sulfonate-styrene copolymer, lithium styrene sulfonate-styrene copolymer, styrene Examples include calcium sulfonate-styrene copolymer, ammonium styrenesulfonate-styrene copolymer, magnesium styrenesulfonate-styrene copolymer, potassium styrenesulfonate-styrene copolymer, lithium styrenesulfonate-styrene copolymer. A polymer, ammonium styrenesulfonate-styrene copolymer, sodium styrenesulfonate-styrene copolymer is preferable, and p-sodium styrenesulfonate-styrene copolymer is more preferable. The styrene sulfonate-styrene copolymer may be used alone or in combination of two or more.
 スチレンスルホン酸塩-スチレン共重合体中におけるスチレンスルホン酸塩成分の含有量は、少ないと、アレルゲン抑制剤のアレルゲン抑制効果が低下することがある。スチレンスルホン酸塩-スチレン共重合体中におけるスチレンスルホン酸塩成分の含有量は、多いと、アレルゲン抑制剤が顔料や染料などの色素と馴染みやすくなって色素が脱落し易くなる。その結果、例えば、黒色などの濃色の繊維にアレルゲン抑制剤を処理した場合、繊維が他の製品と日常生活において擦れることにより、繊維の濃色が他の製品に移り、他の製品を汚染することがある。従って、スチレンスルホン酸塩-スチレン共重合体中におけるスチレンスルホン酸塩成分の含有量は20~45重量%に限定され、25~45重量%が好ましい。 If the content of the styrene sulfonate component in the styrene sulfonate-styrene copolymer is small, the allergen inhibitory effect of the allergen inhibitor may be reduced. When the content of the styrene sulfonate component in the styrene sulfonate-styrene copolymer is large, the allergen inhibitor becomes easily compatible with a pigment such as a pigment or a dye, and the pigment is easily removed. As a result, for example, when dark fibers such as black are treated with an allergen inhibitor, the fibers will rub against other products in daily life, causing the dark color of the fibers to move to other products and contaminating other products. There are things to do. Accordingly, the content of the styrene sulfonate component in the styrene sulfonate-styrene copolymer is limited to 20 to 45% by weight, and preferably 25 to 45% by weight.
 スチレンスルホン酸塩-スチレンスルホン酸-スチレン三元共重合体としては、特に限定されず、例えば、スチレンスルホン酸ナトリウム-スチレンスルホン酸-スチレン三元共重合体、スチレンスルホン酸カリウム-スチレンスルホン酸-スチレン三元共重合体、スチレンスルホン酸リチウム-スチレンスルホン酸-スチレン三元共重合体、スチレンスルホン酸カルシウム-スチレンスルホン酸-スチレン三元共重合体、スチレンスルホン酸アンモニウム-スチレンスルホン酸-スチレン三元共重合体、スチレンスルホン酸マグネシウム-スチレンスルホン酸-スチレン三元共重合体などが挙げられ、スチレンスルホン酸アンモニウム-スチレンスルホン酸-スチレン三元共重合体、スチレンスルホン酸ナトリウム-スチレンスルホン酸-スチレン三元共重合体、スチレンスルホン酸カリウム-スチレンスルホン酸-スチレン三元共重合体、スチレンスルホン酸リチウム-スチレンスルホン酸-スチレン三元共重合体が好ましく、スチレンスルホン酸ナトリウム-スチレンスルホン酸-スチレン三元共重合体がより好ましく、p-スチレンスルホン酸ナトリウム-スチレンスルホン酸-スチレン三元共重合体が特に好ましい。なお、スチレンスルホン酸塩-スチレンスルホン酸-スチレン三元共重合体は、単独で用いられても二種以上が併用されてもよい。 The styrene sulfonate-styrene sulfonic acid-styrene terpolymer is not particularly limited. For example, sodium styrene sulfonate-styrene sulfonic acid-styrene terpolymer, potassium styrene sulfonate-styrene sulfonic acid- Styrene terpolymer, lithium styrene sulfonate-styrene sulfonic acid-styrene terpolymer, calcium styrene sulfonate-styrene sulfonic acid-styrene terpolymer, ammonium styrene sulfonate-styrene sulfonic acid-styrene ternary Examples include styrene copolymer, magnesium styrene sulfonate-styrene sulfonic acid-styrene terpolymer, and ammonium styrene sulfonate-styrene sulfonic acid-styrene terpolymer, sodium styrene sulfonate-styrene sulfonic acid. Preferred are styrene terpolymer, potassium styrene sulfonate-styrene sulfonic acid-styrene terpolymer, lithium styrene sulfonate-styrene sulfonic acid-styrene terpolymer, sodium styrene sulfonate-styrene sulfonic acid- Styrene terpolymers are more preferred, and p-sodium styrene sulfonate-styrene sulfonic acid-styrene terpolymers are particularly preferred. The styrene sulfonate-styrene sulfonic acid-styrene terpolymer may be used alone or in combination of two or more.
 スチレンスルホン酸塩-スチレンスルホン酸-スチレン三元共重合体中におけるスチレンスルホン酸塩成分の含有量は、少ないと、アレルゲン抑制剤のアレルゲン抑制効果が低下することがある。スチレンスルホン酸塩-スチレンスルホン酸-スチレン三元共重合体中におけるスチレンスルホン酸塩成分の含有量は、多いと、アレルゲン抑制剤が顔料や染料などの色素と馴染みやすくなって色素が脱落し易くなる。その結果、例えば、黒色などの濃色の繊維にアレルゲン抑制剤を処理した場合、繊維が他の製品と日常生活において擦れることにより、繊維の濃色が他の製品に移り、他の製品を汚染することがある。従って、スチレンスルホン酸塩-スチレンスルホン酸-スチレン三元共重合体中におけるスチレンスルホン酸塩成分の含有量は20~45重量%に限定され、25~45重量%が好ましい。 If the content of the styrene sulfonate component in the styrene sulfonate-styrene sulfonate-styrene terpolymer is small, the allergen inhibitory effect of the allergen inhibitor may be reduced. If the content of the styrene sulfonate component in the styrene sulfonate-styrene sulfonic acid-styrene terpolymer is high, the allergen inhibitor will be easily compatible with pigments such as pigments and dyes, and the pigments will easily fall off. Become. As a result, for example, when dark fibers such as black are treated with an allergen inhibitor, the fibers will rub against other products in daily life, causing the dark color of the fibers to move to other products and contaminating other products. There are things to do. Accordingly, the content of the styrene sulfonate component in the styrene sulfonate-styrene sulfonic acid-styrene terpolymer is limited to 20 to 45% by weight, and preferably 25 to 45% by weight.
 スチレンスルホン酸塩-スチレンスルホン酸-スチレン三元共重合体中におけるスチレンスルホン酸成分の含有量は、多いと、スチレンスルホン酸塩-スチレンスルホン酸-スチレン三元共重合体の酸性が強くなり、アレルゲン抑制剤で処理するアレルゲン対象物を傷めることがあるので、10重量%以下が好ましく、3重量%以下がより好ましい。 When the content of the styrene sulfonic acid component in the styrene sulfonate-styrene sulfonic acid-styrene terpolymer is large, the acidity of the styrene sulfonate-styrene sulfonic acid-styrene terpolymer becomes strong, Since the allergen target to be treated with the allergen inhibitor may be damaged, it is preferably 10% by weight or less, more preferably 3% by weight or less.
 ポリスチレンのスルホン化体としては、ポリスチレンのベンゼン環の一部をスルホン化した重合体のスルホン酸基の一部又は全てを塩とした重合体が挙げられ、ポリスチレンのベンゼン環の一部をスルホン化した重合体のスルホン酸基の全てを塩とした重合体が好ましい。ポリスチレンのスルホン化体としては、例えば、ポリスチレンのベンゼン環の一部をスルホン化した重合体のスルホン酸基の全てをナトリウム塩とした重合体、ポリスチレンのベンゼン環の一部をスルホン化した重合体のスルホン酸基の一部をナトリウム塩とした重合体、ポリスチレンのベンゼン環の一部をスルホン化した重合体のスルホン酸基の全てをアンモニウム塩とした重合体、ポリスチレンのベンゼン環の一部をスルホン化した重合体のスルホン酸基の一部をアンモニウム塩とした重合体、ポリスチレンのベンゼン環の一部をスルホン化した重合体のスルホン酸基の全てをカルシウム塩とした重合体、ポリスチレンのベンゼン環の一部をスルホン化した重合体のスルホン酸基の一部をカルシウム塩とした重合体などが挙げられる。 Examples of the sulfonated polystyrene include polymers in which a part or all of the sulfonic acid group of a polymer obtained by sulfonating a part of the polystyrene benzene ring is a salt, and a part of the polystyrene benzene ring is sulfonated. A polymer in which all of the sulfonic acid groups of the obtained polymer are salts is preferred. Examples of the polystyrene sulfonated polymer include a polymer in which all of the sulfonic acid groups of a polymer obtained by sulfonating a part of the polystyrene benzene ring are sodium salts, and a polymer in which a part of the polystyrene benzene ring is sulfonated. A polymer in which a part of the sulfonic acid group is a sodium salt, a polymer in which a part of the polystyrene benzene ring is sulfonated, a polymer in which all of the sulfonic acid group is an ammonium salt, and a part of the polystyrene benzene ring A polymer in which a part of the sulfonic acid group of the sulfonated polymer is an ammonium salt, a polymer in which all of the sulfonic acid group of a polymer in which a part of the benzene ring of polystyrene is sulfonated is a calcium salt, a benzene in polystyrene Examples thereof include a polymer in which a part of the sulfonic acid group of a polymer obtained by sulfonating a part of the ring is a calcium salt.
 ポリスチレンのスルホン化体中におけるスチレンスルホン酸塩成分の含有量は、少ないと、アレルゲン抑制剤のアレルゲン抑制効果が低下することがある。ポリスチレンのスルホン化体中におけるスチレンスルホン酸塩成分の含有量は、多いと、アレルゲン抑制剤が顔料や染料などの色素と馴染みやすくなって色素が脱落し易くなる。その結果、例えば、黒色などの濃色の繊維にアレルゲン抑制剤を処理した場合、繊維が他の製品と日常生活において擦れることにより、繊維の濃色が他の製品に移り、他の製品を汚染することがある。ポリスチレンのスルホン化体中におけるスチレンスルホン酸塩成分の含有量は、20~45重量%に限定され、25~45重量%が好ましい。 If the content of the styrene sulfonate component in the sulfonated polystyrene is small, the allergen inhibitory effect of the allergen inhibitor may be reduced. If the content of the styrene sulfonate component in the polystyrene sulfonated product is large, the allergen inhibitor becomes easily compatible with pigments such as pigments and dyes, and the pigments easily fall off. As a result, for example, when dark fibers such as black are treated with an allergen inhibitor, the fibers will rub against other products in daily life, causing the dark color of the fibers to move to other products and contaminating other products. There are things to do. The content of the styrene sulfonate component in the sulfonated polystyrene is limited to 20 to 45% by weight, and preferably 25 to 45% by weight.
 ポリスチレンのスルホン化体中にはスチレンスルホン酸成分を含有しない方が好ましいが、スチレンスルホン酸成分を含有する場合のスチレンスルホン酸成分の含有量は、多いと、ポリスチレンのスルホン化体の酸性が強くなり、処理するアレルゲン対象物を傷めることがあるので、10重量%以下が好ましく、3重量%以下がより好ましい。 It is preferable not to contain a styrene sulfonic acid component in the polystyrene sulfonated product. However, if the styrene sulfonic acid component is contained in a large amount, the polystyrene sulfonated product has a strong acidity. Thus, the allergen object to be treated may be damaged, so that it is preferably 10% by weight or less, and more preferably 3% by weight or less.
 スチレン系重合体の重量平均分子量(Mw)は、低いと、アレルゲン抑制剤のアレルゲン抑制効果が低下することがあるので、2000以上が好ましく、20000以上がより好ましいが、高すぎると、アレルゲン抑制剤の取扱い性が低下することがあるので、100万以下が好ましい。 If the weight average molecular weight (Mw) of the styrenic polymer is low, the allergen inhibitory effect of the allergen inhibitor may decrease, so 2000 or more is preferable, and 20000 or more is more preferable, but if it is too high, the allergen inhibitor. Is less than 1,000,000.
 なお、本発明において、スチレン系重合体の重量平均分子量は、サイズ排除クロマトグラフィーでポリスチレンスルホン酸ナトリウムを標準物質として測定した際のピークトップの値をいう。スチレン系重合体の重量平均分子量は、例えば、下記の条件にて測定することができる。 In the present invention, the weight average molecular weight of the styrene polymer refers to a peak top value when measured by size exclusion chromatography using sodium polystyrene sulfonate as a standard substance. The weight average molecular weight of the styrene polymer can be measured, for example, under the following conditions.
 カラム:(昭和電工社製Shodex GF-7M HQ 7.6mmI.D.×30cm 1本)
 溶離液:(0.05M硫酸ナトリウム水溶液:THF=1:1)
 流速:0.6ミリリットル/分
 温度:40℃
 検出:UV(210nm)
 標準ポリスチレンスルホン酸ナトリウム:(scientific polymer products社製、重量平均分子量(Mw):1,530、5,180、7,540、34,700、126,700、262,600、587,600の7種類の標準品を使用) 
Column: (Showa Denko Shodex GF-7M HQ 7.6mmI.D. × 30cm 1)
Eluent: (0.05 M aqueous sodium sulfate: THF = 1: 1)
Flow rate: 0.6 ml / min Temperature: 40 ° C
Detection: UV (210 nm)
Standard sodium polystyrene sulfonate: (Scientific polymer products, weight average molecular weight (Mw): 1,530, 5,180, 7,540, 34,700, 126,700, 262,600, 587,600)
 アレルゲン抑制剤は、構成成分に応じて所定種類及び所定量の単量体を用意し、この単量体を汎用の要領で共重合させることによって得ることができる。又、アレルゲン抑制剤は、スチレン-マレイン酸共重合体などのスチレン骨格を有する共重合体又はポリスチレンのベンゼン環の一部をスルホン化し、導入されたスルホン酸基をアルカリ水溶液で中和することによっても得ることができる。例えば、ポリスチレンのベンゼン環の一部をスルホン化し、ベンゼン環に結合しているスルホン酸基の全てをアルカリ水溶液で中和してスチレンスルホン酸塩-スチレン共重合体を得ることができる。ポリスチレンのベンゼン環の一部をスルホン化し、ベンゼン環に結合しているスルホン酸基の一部をアルカリ水溶液で中和してスチレンスルホン酸塩-スチレンスルホン酸-スチレン共重合体を得ることができる。なお、アルカリ水溶液としては、例えば、水酸化ナトリウム、水酸化カリウム、水酸化マグネシウム、水酸化アンモニウムなどが挙げられる。 The allergen inhibitor can be obtained by preparing a predetermined type and a predetermined amount of monomer according to the constituent components and copolymerizing the monomer in a general manner. Further, the allergen inhibitor can be obtained by sulfonating a part of a benzene ring of a copolymer having a styrene skeleton such as a styrene-maleic acid copolymer or polystyrene, and neutralizing the introduced sulfonic acid group with an alkaline aqueous solution. Can also be obtained. For example, a styrene sulfonate-styrene copolymer can be obtained by sulfonating a part of the benzene ring of polystyrene and neutralizing all sulfonic acid groups bonded to the benzene ring with an alkaline aqueous solution. Part of the benzene ring of polystyrene is sulfonated, and part of the sulfonic acid group bonded to the benzene ring is neutralized with an alkaline aqueous solution to obtain a styrenesulfonate-styrenesulfonic acid-styrene copolymer. . Examples of the alkaline aqueous solution include sodium hydroxide, potassium hydroxide, magnesium hydroxide, and ammonium hydroxide.
 ポリスチレンのスルホン化は、公知の要領で行うことができ、例えば、三酸化イオウや濃硫酸などを用いる方法などが挙げられる。 The sulfonation of polystyrene can be carried out in a known manner, and examples thereof include a method using sulfur trioxide or concentrated sulfuric acid.
 上記スチレン系重合体の平均粒子径は、特に限定されないが、アレルゲン抑制剤でアレルゲン対象物を処理して得られたアレルゲン抑制製品の意匠性の観点から、0.01~30μmが好ましく、0.05~10μmがより好ましい。なお、上記スチレン系重合体の平均粒子径は、粒子径分布測定装置によって測定された値をいう。粒子径分布測定装置としては、HORIBA製作所から商品名「LA-950V2」にて市販されている装置を用いることができる。 The average particle size of the styrenic polymer is not particularly limited, but is preferably from 0.01 to 30 μm from the viewpoint of design of an allergen-suppressed product obtained by treating an allergen object with an allergen inhibitor. A thickness of 05 to 10 μm is more preferable. The average particle size of the styrenic polymer is a value measured by a particle size distribution measuring device. As the particle size distribution measuring apparatus, an apparatus commercially available from HORIBA Ltd. under the trade name “LA-950V2” can be used.
 また、アレルゲン抑制剤が非水溶性であると、生活用品などのような、アレルゲンが存在し或いはアレルゲンが将来に存在する可能性のある対象物、即ち、アレルゲンを抑制したい対象物(以下、「アレルゲン対象物」という)が水に接触した場合にあってもアレルゲン抑制剤が水に溶解して消失するのを抑制することができ、後述するアレルゲン抑制製品のアレルゲン抑制効果を長期間に亘って安定的に持続させることができる。従って、アレルゲン抑制剤は非水溶性であることが好ましい。なお、アレルゲン対象物から人体及び動物は除外される。又、アレルゲン抑制剤が水溶性である場合は非水溶性とすることが好ましい。ここで、非水溶性とは、20℃で且つpHが5~9である水100gに対して溶解可能なグラム数(以下「溶解度」という)が1以下であることをいい、1を超えるものを水溶性という。 In addition, if the allergen inhibitor is water-insoluble, the allergen may be present or an allergen may be present in the future, such as a household article, that is, an object for which allergen is desired to be suppressed (hereinafter, “ Even when the "allergen object" is in contact with water, the allergen inhibitor can be prevented from dissolving and disappearing in water, and the allergen inhibitory effect of the allergen inhibitor product described below can be maintained over a long period of time. It can be sustained stably. Therefore, the allergen inhibitor is preferably water-insoluble. Human bodies and animals are excluded from allergen objects. Further, when the allergen inhibitor is water-soluble, it is preferable to make it water-insoluble. Here, water-insoluble means that the number of grams that can be dissolved in 100 g of water having a pH of 5 to 9 at 20 ° C. (hereinafter referred to as “solubility”) is 1 or less. Is called water-soluble.
 アレルゲン抑制剤を非水溶性にする方法としては、水溶性のスチレン系重合体に硬化剤を含有させてスチレン系重合体を架橋させる方法、水溶性のスチレン系重合体を担持体に固定させる方法などが挙げられる。 As a method for making an allergen inhibitor water-insoluble, a method for crosslinking a styrene polymer by containing a curing agent in a water-soluble styrene polymer, a method for fixing a water-soluble styrene polymer to a carrier Etc.
 上記スチレン系重合体の硬化剤としては、スチレン系重合体を架橋させることができれば、特に限定されず、例えば、アミン化合物、アミン化合物から合成されるポリアミノアミド化合物などの化合物、3級アミン化合物、イミダゾール化合物、ヒドラジド化合物、メラミン化合物、酸無水物、フェノール化合物、熱潜在性カチオン重合触媒、光潜在性カチオン重合開始剤、ジシアンアミド及びその誘導体、ジビニルベンゼンなどが挙げられ、単独で用いられても2種以上が併用されてもよい。 The curing agent for the styrenic polymer is not particularly limited as long as the styrenic polymer can be crosslinked. For example, amine compounds, compounds such as polyaminoamide compounds synthesized from amine compounds, tertiary amine compounds, Examples include imidazole compounds, hydrazide compounds, melamine compounds, acid anhydrides, phenolic compounds, thermal latent cationic polymerization catalysts, photolatent cationic polymerization initiators, dicyanamide and derivatives thereof, and divinylbenzene. More than one species may be used in combination.
 上記アミン化合物としては、特に限定されず、例えば、エチレンジアミン、ジエチレントリアミン、トリエチレンテトラミン、テトラエチレンペンタミン、ポリオキシプロピレンジアミン、ポリオキシプロピレントリアミンなどの脂肪族アミン及びその誘導体;メンセンジアミン、イソフォロンジアミン、ビス(4-アミノ-3-メチルシクロヘキシル)メタン、ジアミノジシクロヘキシルメタン、ビス(アミノメチル)シクロヘキサン、N-アミノエチルピペラジン、3,9-ビス(3-アミノプロピル)2,4,8,10-テトラオキサスピロ(5,5)ウンデカンなどの脂環式アミン及びその誘導体;m-キシレンジアミン、α-(m-アミノフェニル)エチルアミン、α-(p-アミノフェニル)エチルアミン、m-フェニレンジアミン、ジアミノジフェニルメタン、ジアミノジフェニルスルフォン、α,α-ビス(4-アミノフェニル)-p-ジイソプロピルベンゼンなどの芳香族アミン及びその誘導体などが挙げられる。 The amine compound is not particularly limited. For example, aliphatic amines such as ethylenediamine, diethylenetriamine, triethylenetetramine, tetraethylenepentamine, polyoxypropylenediamine, polyoxypropylenetriamine, and derivatives thereof; mensendiamine, isophorone Diamine, bis (4-amino-3-methylcyclohexyl) methane, diaminodicyclohexylmethane, bis (aminomethyl) cyclohexane, N-aminoethylpiperazine, 3,9-bis (3-aminopropyl) 2,4,8,10 Alicyclic amines such as tetraoxaspiro (5,5) undecane and derivatives thereof; m-xylenediamine, α- (m-aminophenyl) ethylamine, α- (p-aminophenyl) ethylamine, m-phenylenedia And aromatic amines such as amine, diaminodiphenylmethane, diaminodiphenylsulfone, α, α-bis (4-aminophenyl) -p-diisopropylbenzene, and derivatives thereof.
 又、上記アミン化合物から合成される化合物としては、特に限定されず、例えば、上記アミン化合物と、コハク酸、アジピン酸、アゼライン酸、セバシン酸、ドデカ二酸、イソフタル酸、テレフタル酸、ジヒドロイソフタル酸、テトラヒドロイソフタル酸、ヘキサヒドロイソフタル酸などのカルボン酸化合物とから合成されるポリアミノアミド化合物及びその誘導体;上記アミン化合物と、ジアミノジフェニルメタンビスマレイミドなどのマレイミド化合物とから合成されるポリアミノイミド化合物及びその誘導体;上記アミン化合物とケトン化合物とから合成されるケチミン化合物及びその誘導体;上記アミン化合物と、エポキシ化合物、尿素、チオ尿素、アルデヒド化合物、フェノール化合物、アクリル化合物などの化合物とから合成されるポリアミノ化合物及びその誘導体などが挙げられる。 The compound synthesized from the amine compound is not particularly limited. For example, the amine compound and succinic acid, adipic acid, azelaic acid, sebacic acid, dodecadic acid, isophthalic acid, terephthalic acid, dihydroisophthalic acid. , Polyaminoamide compounds synthesized from carboxylic acid compounds such as tetrahydroisophthalic acid and hexahydroisophthalic acid and derivatives thereof; polyaminoimide compounds synthesized from the above amine compounds and maleimide compounds such as diaminodiphenylmethane bismaleimide and derivatives thereof A ketimine compound synthesized from the amine compound and a ketone compound and a derivative thereof; synthesized from the amine compound and a compound such as an epoxy compound, urea, thiourea, an aldehyde compound, a phenol compound, or an acrylic compound. Polyamino compounds and derivatives thereof are exemplified.
 更に、上記3級アミン化合物としては、特に限定されず、例えば、N,N-ジメチルピペラジン、ピリジン、ピコリン、ベンジルジメチルアミン、2-(ジメチルアミノメチル)フェノール、2,4,6-トリス(ジメチルアミノメチル)フェノール、1,8-ジアザビスシクロ(5,4,0)ウンデセン-1及びその誘導体などが挙げられる。 Further, the tertiary amine compound is not particularly limited. For example, N, N-dimethylpiperazine, pyridine, picoline, benzyldimethylamine, 2- (dimethylaminomethyl) phenol, 2,4,6-tris (dimethyl) Aminomethyl) phenol, 1,8-diazabiscyclo (5,4,0) undecene-1 and derivatives thereof.
 そして、上記イミダゾール化合物としては、特に限定されず、例えば、2-メチルイミダゾール、2-エチル-4-メチルイミダゾール、2-ウンデシルイミダゾール、2-ヘプタデシルイミダゾール、2-フェニルイミダゾール及びその誘導体などが挙げられる。 The imidazole compound is not particularly limited, and examples thereof include 2-methylimidazole, 2-ethyl-4-methylimidazole, 2-undecylimidazole, 2-heptadecylimidazole, 2-phenylimidazole and derivatives thereof. Can be mentioned.
 又、上記ヒドラジド化合物としては、特に限定されず、例えば、1,3-ビス(ヒドラジノカルボエチル)-5-イソプロピルヒダントイン、7,11-オクタデカジエン-1,18-ジカルボヒドラジド、エイコサン二酸ジヒドラジド、アジピン酸ジヒドラジド及びその誘導体などが挙げられる。 Further, the hydrazide compound is not particularly limited, and for example, 1,3-bis (hydrazinocarboethyl) -5-isopropylhydantoin, 7,11-octadecadien-1,18-dicarbohydrazide, eicosan Examples thereof include acid dihydrazide, adipic acid dihydrazide and derivatives thereof.
 更に、上記メラミン化合物としては、特に限定されず、例えば、2,4-ジアミノ-6-ビニル-1,3,5-トリアジン及びその誘導体などが挙げられる。 Furthermore, the melamine compound is not particularly limited, and examples thereof include 2,4-diamino-6-vinyl-1,3,5-triazine and derivatives thereof.
 そして、上記酸無水物としては特に限定されず、例えば、フタル酸無水物、トリメリット酸無水物、ピロメリット酸無水物、ベンゾフェノンテトラカルボン酸無水物、エチレングリコールビスアンヒドロトリメリテート、グリセロールトリスアンヒドロトリメリテート、メチルテトラヒドロ無水フタル酸、テトラヒドロ無水フタル酸、ナジック酸無水物、メチルナジック酸無水物、トリアルキルテトラヒドロ無水フタル酸、ヘキサヒドロ無水フタル酸、メチルヘキサヒドロ無水フタル酸、5-(2,5-ジオキソテトラヒドロフリル)-3-メチル-3-シクロヘキセン-1,2-ジカルボン酸無水物、トリアルキルテトラヒドロ無水フタル酸-無水マレイン酸付加物、ドデセニル無水コハク酸、ポリアゼライン酸無水物、ポリドデカン二酸無水物、クロレンド酸無水物及びその誘導体などが挙げられる。 The acid anhydride is not particularly limited. For example, phthalic acid anhydride, trimellitic acid anhydride, pyromellitic acid anhydride, benzophenone tetracarboxylic acid anhydride, ethylene glycol bisanhydro trimellitate, glycerol tris Anhydrotrimellitate, methyltetrahydrophthalic anhydride, tetrahydrophthalic anhydride, nadic anhydride, methylnadic anhydride, trialkyltetrahydrophthalic anhydride, hexahydrophthalic anhydride, methylhexahydrophthalic anhydride, 5- ( 2,5-dioxotetrahydrofuryl) -3-methyl-3-cyclohexene-1,2-dicarboxylic acid anhydride, trialkyltetrahydrophthalic anhydride-maleic anhydride adduct, dodecenyl succinic anhydride, polyazeline acid anhydride Polydodecane Anhydrides, such as chlorendic anhydride and derivatives thereof.
 又、上記フェノール化合物としては、特に限定されず、例えば、フェノールノボラック、o-クレゾールノボラック、p-クレゾールノボラック、t-ブチルフェノールノボラック、ジシクロペンタジエンクレゾール及びその誘導体などが挙げられる。 The phenol compound is not particularly limited, and examples thereof include phenol novolak, o-cresol novolak, p-cresol novolak, t-butylphenol novolak, dicyclopentadiene cresol and derivatives thereof.
 更に、上記熱潜在性カチオン重合触媒としては、特に限定されず、例えば、6フッ化アンチモン、6フッ化リン、4フッ化ホウ素などを対アニオンとした、ベンジルスルホニウム塩、ベンジルアンモニウム塩、ベンジルピリジニウム塩、ベンジルホスホニウム塩などのイオン性熱潜在性カチオン重合触媒;N-ベンジルフタルイミド、芳香族スルホン酸エステルなどの非イオン性熱潜在性カチオン重合触媒が挙げられる。 Further, the thermal latent cationic polymerization catalyst is not particularly limited. For example, benzylsulfonium salt, benzylammonium salt, benzylpyridinium using antimony hexafluoride, phosphorus hexafluoride, boron tetrafluoride and the like as a counter anion. Examples include ionic thermal latent cationic polymerization catalysts such as salts and benzylphosphonium salts; nonionic thermal latent cationic polymerization catalysts such as N-benzylphthalimide and aromatic sulfonic acid esters.
 そして、上記光潜在性カチオン重合開始剤としては特に限定されず、例えば、6フッ化アンチモン、6フッ化リン、4フッ化ホウ素などを対アニオンとした、芳香族ジアゾニウム塩、芳香族ハロニウム塩及び芳香族スルホニウム塩などのオニウム塩類、並びに、鉄-アレン錯体、チタノセン錯体及びアリールシラノール-アルミニウム錯体などの有機金属錯体類などのイオン性光潜在性カチオン重合開始剤;ニトロベンジルエステル、スルホン酸誘導体、リン酸エステル、フェノールスルホン酸エステル、ジアゾナフトキノン、N-ヒドロキシイミドスルホナートなどの非イオン性光潜在性カチオン重合開始剤が挙げられる。 The photolatent cationic polymerization initiator is not particularly limited. For example, an aromatic diazonium salt, an aromatic halonium salt, and an antimony hexafluoride, phosphorus hexafluoride, boron tetrafluoride, and the like as a counter anion. Ionic photolatent cationic polymerization initiators such as onium salts such as aromatic sulfonium salts and organometallic complexes such as iron-allene complexes, titanocene complexes and arylsilanol-aluminum complexes; nitrobenzyl esters, sulfonic acid derivatives, Nonionic photolatent cationic polymerization initiators such as phosphoric acid ester, phenolsulfonic acid ester, diazonaphthoquinone, N-hydroxyimide sulfonate and the like can be mentioned.
 又、スチレン系重合体を固定させる担持体としては、特に限定されず、例えば、タルク、ベントナイト、クレー、カオリン、珪藻土、シリカ、バーミュライト、パーライトなどの無機担体や、ポリエチレン、ポリプロピレンなどの有機高分子担体などが挙げられる。 The carrier for fixing the styrenic polymer is not particularly limited, and examples thereof include inorganic carriers such as talc, bentonite, clay, kaolin, diatomaceous earth, silica, vermulite, perlite, and organic carriers such as polyethylene and polypropylene. Examples thereof include a polymer carrier.
 有機高分子担体の形態としては、特に限定されず、例えば、微粒子状、繊維状、シート状、フィルム状、発泡体などが挙げられる。スチレン系重合体を発泡体に担持させる場合には、発泡体の原反となる発泡性成形体の発泡前にスチレン系重合体を担持させても発泡後にスチレン系重合体を担持させてもよい。 The form of the organic polymer carrier is not particularly limited, and examples thereof include fine particles, fibers, sheets, films, and foams. When the styrenic polymer is supported on the foam, the styrenic polymer may be supported before foaming of the foamable molded article that is the raw material of the foam, or the styrenic polymer may be supported after foaming. .
 そして、スチレン系重合体を担持体に固定する方法としては、特に限定されないが、例えば、スチレン系重合体を担持体に吸着させる方法、グラフトなどの化学結合やバインダーによる結合によってスチレン系重合体を担持体に固定する方法などが挙げられる。 The method for fixing the styrenic polymer to the support is not particularly limited. For example, a method for adsorbing the styrenic polymer to the support, a chemical bond such as grafting, or a bond with a binder may be used. Examples thereof include a method of fixing to a carrier.
 本発明のアレルゲン抑制剤には、アレルゲン抑制効果の有効性を阻害しない範囲において、分散剤、乳化剤、酸化防止剤、紫外線吸収剤、移染防止剤などの製剤用補助剤が配合されていてもよく、又、殺ダニ剤、殺菌剤、防黴剤、消臭剤などが含有されていてもよい。 The allergen inhibitor of the present invention may contain formulation adjuvants such as a dispersant, an emulsifier, an antioxidant, an ultraviolet absorber, and a dye transfer inhibitor as long as the effectiveness of the allergen suppressing effect is not impaired. In addition, acaricides, bactericides, fungicides, deodorants and the like may be contained.
 移染防止剤としては、特に限定されず、例えば、塩化カルシウムなどの塩類、水溶性カチオン化合物、ポリビニルピロリドン、ポリビニルピリジンベタイン、ポリアミンN-オキシド重合体などが挙げられる。 The dye transfer inhibitor is not particularly limited, and examples thereof include salts such as calcium chloride, water-soluble cationic compounds, polyvinyl pyrrolidone, polyvinyl pyridine betaine, and polyamine N-oxide polymers.
 次に、上記アレルゲン抑制剤の使用要領について説明する。上記アレルゲン抑制剤は、スプレー型、エアゾール型、燻煙型、加熱蒸散型、マトリックスへの混合などの汎用の使用方法を用いることができる。 Next, the procedure for using the allergen inhibitor will be described. For the allergen inhibitor, a general use method such as a spray type, an aerosol type, a smoke type, a heat transpiration type, or a mixture in a matrix can be used.
 上記アレルゲン抑制剤を溶媒に溶解或いは分散させてアレルゲン抑制剤溶液とし、このアレルゲン抑制剤溶液に水溶剤、油剤、乳剤、懸濁剤などを配合することによって、アレルゲン抑制剤をスプレー型とすることができる。なお、スプレー型とは、常圧下にあるアレルゲン抑制剤溶液に圧力を加えてアレルゲン抑制剤を霧状に噴霧する使用方法をいう。 The allergen inhibitor is dissolved or dispersed in a solvent to form an allergen inhibitor solution, and an allergen inhibitor solution is mixed with an aqueous solvent, oil agent, emulsion, suspension, etc. to make the allergen inhibitor spray type. Can do. In addition, a spray type means the usage method which applies a pressure to the allergen inhibitor solution under normal pressure, and sprays an allergen inhibitor in the shape of a mist.
 なお、上記溶媒としては、例えば、水(好ましくは、イオン交換水)、アルコール類(メチルアルコール、エチルアルコール、プロピルアルコールなど)、炭化水素類(トルエン、キシレン、メチルナフタレン、ケロセン、シクロヘキサンなど)、エーテル類(ジエチルエーテル、テトラヒドロフラン、ジオキサンなど)、ケトン類(アセトン、メチルエチルケトンなど)、アミド類(N,N-ジメチルホルムアミドなど)が挙げられる。 Examples of the solvent include water (preferably ion-exchanged water), alcohols (methyl alcohol, ethyl alcohol, propyl alcohol, etc.), hydrocarbons (toluene, xylene, methylnaphthalene, kerosene, cyclohexane, etc.), Examples include ethers (diethyl ether, tetrahydrofuran, dioxane, etc.), ketones (acetone, methyl ethyl ketone, etc.), amides (N, N-dimethylformamide, etc.).
 そして、上記スプレー型のアレルゲン抑制剤に、固体担体(タルク、ベントナイト、クレー、カオリン、珪藻土、シリカ、バーミュライト、パーライトなど)を添加することにより、アレルゲン抑制剤をエアゾール型とすることができる。 Then, by adding a solid carrier (talc, bentonite, clay, kaolin, diatomaceous earth, silica, vermulite, perlite, etc.) to the spray-type allergen inhibitor, the allergen inhibitor can be made into an aerosol type. .
 ここで、エアゾール型とは、容器内にアレルゲン抑制剤溶液を噴射剤と共に該噴射剤が圧縮された状態に封入しておき、噴射剤の圧力によってアレルゲン抑制剤を霧状に噴霧させる使用方法をいう。なお、噴射剤としては、例えば、窒素、炭酸ガス、ジメチルエーテル、LPGなどが挙げられる。 Here, the aerosol type is a method of using an allergen inhibitor solution enclosed in a container together with a propellant in a compressed state, and spraying the allergen inhibitor in the form of a mist by the pressure of the propellant. Say. Examples of the propellant include nitrogen, carbon dioxide, dimethyl ether, and LPG.
 そして、上記スプレー型のアレルゲン抑制剤に、酸素供給剤(過塩素酸カリウム、硝酸カリウム、塩素酸カリウムなど)、燃焼剤(糖類、澱粉など)、発熱調整剤(硝酸グアニジン、ニトログアニジン、リン酸グアニル尿素など)、酸素供給剤分解用助剤(塩化カリウム、酸化銅、酸化クロム、酸化鉄、活性炭など)などを添加することにより、アレルゲン抑制剤を燻煙型することができる。なお、燻煙型とは、アレルゲン抑制剤を微粒子化して煙状とし、分散させる使用方法をいう。 In addition, the spray-type allergen inhibitors include oxygen supply agents (potassium perchlorate, potassium nitrate, potassium chlorate, etc.), combustion agents (sugars, starches, etc.), and exothermic regulators (guanidine nitrate, nitroguanidine, guanyl phosphate). The allergen inhibitor can be smoked by adding an agent for decomposing oxygen (such as urea) and an auxiliary agent for decomposing oxygen supply agents (potassium chloride, copper oxide, chromium oxide, iron oxide, activated carbon, etc.). The smoke type refers to a method of use in which an allergen inhibitor is finely divided into smoke and dispersed.
 又、アレルゲン抑制剤を混合させるマトリックスとしては、アレルゲン抑制剤を変性させないものであれば、特に限定されず、例えば、多糖類やその塩、デキストリン、ゼラチン、高級アルコール、油脂類、ステアリン酸などの高級脂肪酸、パラフィン類、流動パラフィン類、白色ワセリン、ハイドロカーボンゲル軟膏、ポリエチレングリコール、ポリビニルアルコール、ポリアクリル酸ナトリウム、各種塗料などが挙げられる。 The matrix for mixing the allergen inhibitor is not particularly limited as long as it does not denature the allergen inhibitor. For example, polysaccharides and salts thereof, dextrin, gelatin, higher alcohols, fats and oils, stearic acid and the like. Examples include higher fatty acids, paraffins, liquid paraffins, white petrolatum, hydrocarbon gel ointment, polyethylene glycol, polyvinyl alcohol, sodium polyacrylate, and various paints.
 そして、上記アレルゲン抑制剤を、各種使用方法に応じて、アレルゲン対象物に噴霧、分散、塗布又は固着させることによって供給することにより、アレルゲン対象物にアレルゲン抑制効果を付与してアレルゲン抑制製品とし、アレルゲン対象物のアレルゲンを抑制することができる。「アレルゲン対象物」とは、アレルゲンが既に存在する対象物、又は、現在はアレルゲンが存在しないが将来にアレルゲンが存在する可能性のある対象物をいう。なお、アレルゲン対象物から人体及び動物は除外される。アレルゲン対象物に既にアレルゲンが存在している場合には、アレルゲン抑制剤を供給することによってアレルゲンが抑制される。アレルゲン対象物にアレルゲンが存在していない場合は、アレルゲン対象物に予めアレルゲン抑制剤によってアレルゲン抑制効果を付与しておくことによって、アレルゲン対象物にアレルゲンが付着又は発生した場合に、アレルゲン抑制剤がアレルゲンを抑制する。上記アレルゲン抑制剤は、単独で用いられても二種以上が併用されてもよい。アレルゲン抑制剤は、上述のアレルゲン抑制剤溶液に懸濁剤を配合して懸濁液とした場合の安定性に優れていることから、アレルゲン抑制剤を懸濁液としスプレー型としてアレルゲン対象物に噴霧することが好ましい。なお、アレルゲン抑制剤をアレルゲン対象物に化学的又は物理的に固着させる方法としては、後述するアレルゲン抑制剤を繊維に化学的に結合させ或いは物理的に固着させる方法を用いることができる。 And by supplying the allergen inhibitor by spraying, dispersing, applying or fixing to the allergen object according to various methods of use, an allergen inhibitory effect is imparted to the allergen object, and an allergen inhibitor product is obtained. Allergens of the allergen object can be suppressed. An “allergen object” refers to an object in which an allergen already exists, or an object in which no allergen currently exists but an allergen may exist in the future. Human bodies and animals are excluded from allergen objects. When the allergen is already present in the allergen object, the allergen is suppressed by supplying the allergen inhibitor. If the allergen is not present in the allergen object, the allergen inhibitor is applied to the allergen object in advance by providing the allergen inhibitor with an allergen inhibitory effect. Suppress allergens. The allergen inhibitor may be used alone or in combination of two or more. The allergen inhibitor is excellent in stability when a suspension is added to the above-mentioned allergen inhibitor solution to form a suspension. Spraying is preferred. In addition, as a method of chemically or physically fixing the allergen inhibitor to the allergen object, a method of chemically bonding or physically fixing the allergen inhibitor described later to the fiber can be used.
 又、上記アレルゲン対象物としては、生活空間においてアレルゲンの温床となる生活用品などが挙げられる。アレルゲン対象物が繊維、繊維製品の場合に、アレルゲン抑制剤は、その効果をより発揮する。生活用品としては、例えば、畳、絨毯、家具(ソファー、ソファー内部の発泡体、布ばり椅子、テーブルなど)、寝具(ベッド、布団、布団の中綿、羽毛布団の羽毛、シーツ、マットレス、クッション及びこれらを構成している発泡体など)、車、飛行機、船などの車輛内用品及び車輛内装材(シート、チャイルドシート及びこれらを構成している発泡体など)、キッチン用品、ベビー用品、建築内装材(壁紙、床材など)、繊維製品(布帛、カーテン、タオル、衣類、ぬいぐるみなど)、繊維、網戸などのフィルター、網戸、建築内装材などが挙げられる。 In addition, examples of the allergen target include daily items that serve as a hotbed for allergens in a living space. When the allergen object is a fiber or a fiber product, the allergen inhibitor exhibits its effect more. Living items include, for example, tatami mats, carpets, furniture (sofas, foam inside sofas, cloth chairs, tables, etc.), bedding (beds, futons, futon batting, duvet feathers, sheets, mattresses, cushions, etc. Foams that make up these, etc.) Car interior items such as cars, airplanes, ships, and vehicle interior materials (seats, child seats and foams that make up these), kitchen items, baby items, architectural interior materials (Wallpaper, flooring, etc.), textile products (fabrics, curtains, towels, clothing, stuffed animals, etc.), textiles, filters such as screen doors, screen doors, and building interior materials.
 特に、本発明のアレルゲン抑制剤は、不測の着色や、日常の生活環境における変色が殆どなく、更に、色移りの問題も殆どないことから、光による退色、変色、又は、擦れによる他製品への色移りによる汚染が課題となる用途、例えば、繊維製品、建築内装材、車輛内用品、車輛内装材、フィルターなどに適している。 In particular, since the allergen inhibitor of the present invention has almost no unexpected coloration or discoloration in the daily living environment, and there is almost no problem of color transfer, it can be applied to other products caused by light fading, discoloration, or rubbing. It is suitable for applications in which contamination due to color transfer is a problem, for example, textile products, building interior materials, vehicle interior products, vehicle interior materials, filters, and the like.
 上記フィルターとは、分離、濾過、異物を排除する能力を有するものをいい、例えば、空気清浄機、エアコン、掃除機、換気扇などのフィルターや、埃や花粉などの進入を防ぐマスク、障子、虫などの進入を防ぐ網戸やカヤなどを挙げることができる。 The above filter refers to a filter having the ability to separate, filter, and remove foreign substances. For example, a filter such as an air cleaner, an air conditioner, a vacuum cleaner, a ventilation fan, a mask that prevents entry of dust or pollen, a shoji, an insect, etc. And screen doors and kayaks that prevent entry.
 上記建築内装材とは、特に限定されるものではなく、例えば、床材、壁紙、天井材、塗料、ワックスなどを挙げることができる。 The architectural interior material is not particularly limited, and examples thereof include floor materials, wallpaper, ceiling materials, paints, and waxes.
 上記繊維製品とは、特に限定されるものではなく、例えば、布帛、寝具、カーペット、カーテン、タオル、衣類、ぬいぐるみなどを挙げることができる。 The fiber product is not particularly limited, and examples thereof include fabrics, bedding, carpets, curtains, towels, clothes, and stuffed animals.
 上記車輛内用品及び車輛内装材とは、特に限定されるものではなく、例えば、シート、チャイルドシート、シートベルト、カーマット、シートカバー、絨毯などを挙げることができる。 The vehicle interior and vehicle interior materials are not particularly limited, and examples thereof include a seat, a child seat, a seat belt, a car mat, a seat cover, and a carpet.
 アレルゲン対象物に対するアレルゲン抑制剤の使用量としては、少ないと、アレルゲン抑制剤のアレルゲン抑制効果が発現しないことがある一方、多いと、アレルゲン対象物を痛めることがあるので、アレルゲン対象物100重量部に対して0.001~100重量部が好ましく、0.01~50重量部がより好ましく、0.02~30重量部が特に好ましく、0.02~20重量部が最も好ましい。 When the amount of the allergen inhibitor used for the allergen object is small, the allergen inhibitory effect of the allergen inhibitor may not be manifested. On the other hand, when the amount is large, the allergen object may be damaged. Is preferably 0.001 to 100 parts by weight, more preferably 0.01 to 50 parts by weight, particularly preferably 0.02 to 30 parts by weight, and most preferably 0.02 to 20 parts by weight.
 本発明のアレルゲン抑制剤が対象とするアレルゲンとしては、ヒョウヒダニのアレルゲン(Der1、Der2)、犬や猫に起因するアレルゲン(Can f1、Fel d1)などの動物性アレルゲン、空気中に浮遊するスギ花粉アレルゲン(Cryj1、Cryj2)、花粉などの植物性アレルゲンが挙げられる。特に効果のある動物アレルゲンとしては、ダニ類のアレルゲン(ダニ類、節足動物一蛛形綱-ダニ目の生物で、主に7つの亜目に分かれている。アシナガダニに代表される背気門、カタダニに代表される四気門、ヤマトマダニ、ツバメヒメダニに代表される後気門、イエダニ、スズメサシダニ代表される中気門、クワガタツメダニ、ナミホコリダニに代表される前気門、コナヒョウヒダニなどのヒョウヒダニ類、ケナガコナダニに代表される無気門、イエササラダニ、カザリヒワダニに代表される隠気門など)のいずれの種類でも対象となり得るが、室内塵中、特に寝具類に多く、アレルギー疾患の原因となるヒョウヒダニ類に特に効果がある。 The allergens targeted by the allergen inhibitor of the present invention include leopard mite allergens (Der1, Der2), animal allergens such as dogs and cats (Can f1, Fel d1), and cedar pollen floating in the air. Examples include allergens (Cryj1, Cryj2) and plant allergens such as pollen. Animal allergens that are particularly effective include mite allergens (mites, arthropod ginsengs-mite organisms, which are mainly divided into seven subtypes. , Anterospira represented by ticks, mite, posterior genus represented by spider mite, middle antrum represented by house dust mite, spider mite, anterior genus represented by staghorn tick, nymph mite, leopard mites such as mite It can be a target for any type of anatomical gates such as Kenagakonadani, Jesa Saladani, and Hidden Gates represented by Kasari Mite, but it is often found in indoor dust, especially bedding, and causes allergic diseases. Is particularly effective.
 上述のアレルゲン抑制剤の使用要領によれば、アレルゲン対象物に必要に応じてアレルゲン抑制剤を供給することによって、アレルゲン対象物に存在し或いは将来、存在するであろうアレルゲンの特異抗体に対する反応性を抑制するものであった。 According to the above-mentioned guidelines for the use of an allergen inhibitor, the allergen inhibitor is supplied with an allergen inhibitor as necessary, thereby reacting the allergen object with a specific antibody that may or may be present in the allergen object in the future. Was to suppress.
 上記アレルゲン抑制剤を繊維に含有させてアレルゲン抑制繊維とし、繊維自体にアレルゲン抑制効果を付与してもよい。このアレルゲン抑制繊維を用いて上記生活用品を作製することによって、生活用品にアレルゲン抑制効果を予め付与しておくことができる。 The above-mentioned allergen inhibitor may be contained in a fiber to form an allergen-suppressing fiber, and the allergen suppressing effect may be imparted to the fiber itself. By producing the above-mentioned daily necessities using this allergen-suppressing fiber, the allergen-inhibiting effect can be imparted to the daily necessities in advance.
 アレルゲン抑制剤を繊維に含有させる方法としては、繊維にアレルゲン抑制剤を化学的に結合させ或いは物理的に固着させる方法が挙げられる。そして、繊維としては、アレルゲン抑制剤を含有させることができるものであれば、特に限定されず、例えば、ポリエステル繊維、ナイロン繊維、アクリル系繊維、ポリオレフィン系繊維などの合成繊維、アセテート繊維などの半合成繊維、キュプラ、レーヨンなどの再生繊維、綿、麻、羊毛、絹などの天然繊維、又は、これら各種繊維の複合化繊維、混綿などが挙げられる。 Examples of the method of incorporating the allergen inhibitor into the fiber include a method of chemically binding or physically fixing the allergen inhibitor to the fiber. The fiber is not particularly limited as long as it can contain an allergen inhibitor. For example, a synthetic fiber such as a polyester fiber, a nylon fiber, an acrylic fiber, or a polyolefin fiber, or a half of an acetate fiber or the like. Examples thereof include synthetic fibers, recycled fibers such as cupra and rayon, natural fibers such as cotton, hemp, wool, and silk, or composite fibers and mixed cottons of these various fibers.
 上記アレルゲン抑制剤を繊維に化学的に結合させる要領としては、グラフト化反応により繊維にアレルゲン抑制剤を化学的に結合させる方法が挙げられる。グラフト化反応としては、特に限定されず、例えば、(1)繊維となる幹ポリマーに重合開始点をつくり、アレルゲン抑制剤を枝ポリマーとして重合させるグラフト重合方法、(2)アレルゲン抑制剤を高分子反応によって繊維に化学的に結合させる高分子反応法などが挙げられる。 The method for chemically binding the allergen inhibitor to the fiber includes a method of chemically binding the allergen inhibitor to the fiber by a grafting reaction. The grafting reaction is not particularly limited.For example, (1) a graft polymerization method in which a polymerization initiation point is created in a trunk polymer to be a fiber, and an allergen inhibitor is polymerized as a branch polymer; (2) an allergen inhibitor is a polymer Examples thereof include a polymer reaction method in which the fiber is chemically bonded to the fiber by reaction.
 グラフト重合方法としては、例えば、(1)繊維への連鎖移動反応を利用し、ラジカルを生成し重合する方法、(2)第2セリウム塩や硫酸銀塩などをアルコール、チオール、アミンのような還元性物質を作用させて酸化還元系(レドックス系)を形成し、繊維にフリーラジカルを生成して重合を行う方法、(3)繊維と、スチレン系重合体の原料となる単量体とを共存させた状態で、繊維にγ線や加速電子線を照射する方法、(4)γ線や加速電子線を繊維だけに照射し、その後にスチレン系重合体の原料となる単量体を加えて重合を行う方法、(5)繊維を構成する高分子を酸化してペルオキシ基を導入し或いは側鎖のアミノ基からジアゾ基を導入して、これを重合開始点として重合する方法、(6)水酸基、アミノ基、カルボキシル基などの側鎖の活性基によるエポキシ、ラクタム、極性ビニルモノマーなどの重合開始反応を利用する方法などが挙げられる。 Examples of the graft polymerization method include (1) a method in which a chain transfer reaction to a fiber is used to generate radicals and polymerize, and (2) a second cerium salt or silver sulfate salt such as alcohol, thiol, or amine. A method in which a reducing substance is allowed to act to form an oxidation-reduction system (redox system), and free radicals are generated in the fiber for polymerization. (3) A fiber and a monomer that is a raw material for the styrene polymer. A method of irradiating the fiber with γ rays or accelerated electron beams in the coexisting state, (4) Irradiating only the fibers with γ rays or accelerated electron beams, and then adding a monomer as a raw material of the styrenic polymer (5) A method in which a polymer constituting the fiber is oxidized to introduce a peroxy group or a diazo group is introduced from an amino group in a side chain, and this is used as a polymerization initiation point, and (6) ) Depending on the side chain active group such as hydroxyl, amino or carboxyl Examples thereof include a method using a polymerization initiation reaction of epoxy, lactam, polar vinyl monomer and the like.
 更に、グラフト重合方法を具体的に列挙する。a)スチレン系重合体の原料となる単量体中でセルロースを磨砕することによってフリーラジカルを生成させてグラフト重合を行う方法。b)スチレン系重合体の原料となる単量体と、繊維として連鎖移動を受けやすい基を持つセルロース誘導体(例えば、メルカプトエチルセルロースなど)を用いてグラフト重合を行う方法。c)オゾンや過酸化物を酸化し、ラジカルを生成させる方法でグラフト重合を行う方法。d)アリルエーテル、ビニルエーテルまたはメタクリル酸エステルなどの二重結合を、セルロースの側鎖に導入してグラフト重合を行う方法。e)アントラキノン-2,7-ジスルホン酸ナトリウムなどを光増感剤として用い、繊維に紫外線を照射してグラフト重合を行う方法。f)カソードの周りに繊維を巻き、希硫酸中に、スチレン系重合体の原料となる単量体を加えて外部電圧を加えることにより電気化学的にグラフト重合を行う方法。 Furthermore, the graft polymerization methods are specifically listed. a) A method of carrying out graft polymerization by generating free radicals by grinding cellulose in a monomer that is a raw material of a styrenic polymer. b) A method of performing graft polymerization using a monomer as a raw material of a styrene polymer and a cellulose derivative (for example, mercaptoethyl cellulose) having a group that is susceptible to chain transfer as a fiber. c) A method in which graft polymerization is performed by oxidizing ozone and peroxide to generate radicals. d) A method of carrying out graft polymerization by introducing a double bond such as allyl ether, vinyl ether or methacrylic acid ester into the side chain of cellulose. e) A method of performing graft polymerization by irradiating a fiber with ultraviolet rays using sodium anthraquinone-2,7-disulfonate as a photosensitizer. f) A method of performing graft polymerization electrochemically by winding fibers around the cathode, adding a monomer as a raw material of the styrene polymer to dilute sulfuric acid, and applying an external voltage.
 繊維へのグラフト重合であることを勘案すれば、下記方法が好ましい。g)メタクリル酸グリシジル(GMA)と過酸化ベンゾイルを塗った繊維を、スチレン系重合体の原料となる単量体溶液中で加熱することによりグラフト重合する方法。h)過酸化ベンゾイル、界面活性剤(非イオン界面活性剤又は陰イオン界面活性剤)及びモノクロロベンゼンを水へ分散させた分散液に、スチレン系重合体の原料となる単量体を加え、繊維として、例えばポリエステル系繊維を浸漬して、加熱してグラフト重合を行う方法。 Considering that the graft polymerization to the fiber, the following method is preferable. g) A method in which a fiber coated with glycidyl methacrylate (GMA) and benzoyl peroxide is graft polymerized by heating in a monomer solution that is a raw material for the styrenic polymer. h) To the dispersion liquid in which benzoyl peroxide, a surfactant (nonionic surfactant or anionic surfactant) and monochlorobenzene are dispersed in water, a monomer which is a raw material for the styrene polymer is added to the fiber. As a method, for example, a polyester fiber is immersed and heated to perform graft polymerization.
 上記高分子反応法としては、汎用の方法が使用でき、例えば、(1)C-Hに対する連鎖移動反応、酸化反応、置換反応、(2)二重結合に対する付加反応、酸化反応、(3)水酸基のエステル化、エーテル化、アセタール化、エステル基やアミド基に対する置換反応、付加反応、加水分解反応、ハロゲン基に対する置換反応、脱離反応、(4)芳香環に対する置換反応(ハロゲン化、ニトロ化、スルホン化、クロルメチル化)などが挙げられる。 As the polymer reaction method, a general-purpose method can be used, for example, (1) chain transfer reaction, oxidation reaction, substitution reaction for C—H, (2) addition reaction for double bond, oxidation reaction, (3) Hydroxyl esterification, etherification, acetalization, substitution reaction for ester group and amide group, addition reaction, hydrolysis reaction, substitution reaction for halogen group, elimination reaction, (4) substitution reaction for aromatic ring (halogenation, nitro , Sulfonation, chloromethylation) and the like.
 次に、アレルゲン抑制剤を繊維に物理的に固着させる方法について説明する。アレルゲン抑制剤を繊維に物理的に固着させる方法としては、例えば、(1)アレルゲン抑制剤を溶剤中に溶解或いは分散させてアレルゲン抑制剤溶液を作製し、このアレルゲン抑制剤溶液中に繊維を含浸させて、繊維にアレルゲン抑制剤溶液を含浸させる方法、(2)上記アレルゲン抑制剤溶液を繊維表面に塗布する方法、(3)上記アレルゲン抑制剤を溶解或いは分散させてなるバインダー中に繊維を浸漬させて、アレルゲン抑制剤をバインダーによって繊維に固着させる方法、(4)上記アレルゲン抑制剤を溶解或いは分散させてなるバインダーを繊維表面に塗布し、アレルゲン抑制剤をバインダーによって繊維に固着させる方法などが挙げられる。なお、上記(1)(2)の方法において、アレルゲン抑制剤溶液中に下記バインダーを含有させてもよい。 Next, a method for physically fixing the allergen inhibitor to the fiber will be described. As a method of physically fixing the allergen inhibitor to the fiber, for example, (1) An allergen inhibitor solution is prepared by dissolving or dispersing the allergen inhibitor in a solvent, and the allergen inhibitor solution is impregnated with the fiber. A method of impregnating the fiber with an allergen inhibitor solution, (2) a method of applying the allergen inhibitor solution to the fiber surface, and (3) immersing the fiber in a binder obtained by dissolving or dispersing the allergen inhibitor. A method of fixing the allergen inhibitor to the fiber with a binder, (4) a method of applying a binder obtained by dissolving or dispersing the allergen inhibitor on the fiber surface, and fixing the allergen inhibitor to the fiber with a binder, etc. Can be mentioned. In the methods (1) and (2), the allergen inhibitor solution may contain the following binder.
 上記溶剤としては、特に限定されず、例えば、水;メチルアルコール、エチルアルコール、プロピルアルコールなどのアルコール類;トルエン、キシレン、メチルナフタレン、ケロセン、シクロヘキサンなどの炭化水素類;ジエチルエーテル、テトラヒドロフラン、ジオキサンなどのエーテル類;アセトン、メチルエチルケトンなどのケトン類;N,N-ジメチルホルムアミドなどのアミド類などが挙げられる。 The solvent is not particularly limited. For example, water; alcohols such as methyl alcohol, ethyl alcohol, and propyl alcohol; hydrocarbons such as toluene, xylene, methylnaphthalene, kerosene, and cyclohexane; diethyl ether, tetrahydrofuran, dioxane, and the like Ethers; ketones such as acetone and methyl ethyl ketone; amides such as N, N-dimethylformamide and the like.
 上記バインダーとしては、アレルゲン抑制剤を繊維表面に固着できるものであれば、特に限定されず、例えば、合成樹脂からなるバインダーとしては、一液型ウレタン樹脂、二液型ウレタン樹脂などのウレタン系樹脂、アクリル樹脂、ウレタンアクリレート樹脂、ポリエステル樹脂、不飽和ポリエステル樹脂、アルキド樹脂、酢酸ビニル樹脂、塩化ビニル樹脂、エポキシ樹脂、エポキシアクリレート樹脂などが挙げられ、ウレタン系樹脂が好ましい。 The binder is not particularly limited as long as it can fix the allergen inhibitor to the fiber surface. For example, the binder made of a synthetic resin may be a urethane resin such as a one-component urethane resin or a two-component urethane resin. Acrylic resin, urethane acrylate resin, polyester resin, unsaturated polyester resin, alkyd resin, vinyl acetate resin, vinyl chloride resin, epoxy resin, epoxy acrylate resin, and the like, and urethane resin is preferable.
 又、上記では、アレルゲン抑制剤を別途製造された繊維に化学的に結合させ或いは物理的に固着させることによって、繊維にアレルゲン抑制剤を含有させる要領を説明したが、アレルゲン抑制剤を化学的に結合させた繊維原料を紡糸して繊維を作製してもよい。 In the above description, the allergen inhibitor is chemically bonded to a separately manufactured fiber, or physically fixed, so that the allergen inhibitor is contained in the fiber. Fibers may be produced by spinning the combined fiber raw material.
 アレルゲン抑制剤を化学的に結合させた繊維原料の作製要領としては、特に限定されず、例えば、一般式(1)で示される構造式の単量体と、一般の繊維原料となる単量体とを一般式(1)で示される構造式の単量体が20~45重量%含有されるように共重合させて繊維原料を作製する方法が挙げられる。 The production method of the fiber raw material in which the allergen inhibitor is chemically bonded is not particularly limited. For example, the monomer having the structural formula represented by the general formula (1) and the monomer to be a general fiber raw material And a method of preparing a fiber raw material by copolymerizing such that the monomer having the structural formula represented by the general formula (1) is contained in an amount of 20 to 45% by weight.
 本発明のアレルゲン抑制剤は、上記一般式(1)で示される構造式の単量体成分を20~45重量%含有するスチレン系重合体を含有しているので、アレルゲンが特異抗体と反応するのを効果的に抑制し、アレルギー症状の軽減或いはその発現の予防をすることができる。更に、本発明のアレルゲン抑制剤は、不測の変色や日常の使用条件下での変色が生じにくく、各種生活用品に好適に用いることができる。 Since the allergen inhibitor of the present invention contains a styrene polymer containing 20 to 45% by weight of the monomer component having the structural formula represented by the general formula (1), the allergen reacts with a specific antibody. Can be effectively suppressed, and allergic symptoms can be reduced or the occurrence thereof can be prevented. Furthermore, the allergen inhibitor of the present invention is less susceptible to unexpected discoloration or discoloration under daily use conditions, and can be suitably used for various daily necessities.
 本発明のアレルゲン抑制剤は、アレルゲン対象物に処理して、アレルゲン対象物に優れたアレルゲン抑制効果を付与することができる。アレルゲン対象物が、顔料又は染料などの色素によって着色されている布帛などの繊維製品又は繊維であっても、アレルゲン抑制剤を処理したアレルゲン対象物が他の製品と擦れることによって他の製品に色移りが生じることはない。従って、他の製品への色移りによるアレルゲン対象物の色落ちや、他の製品がアレルゲン対象物からの色移りによって汚染されることを防止することができる。 The allergen inhibitor of the present invention can be applied to an allergen object to impart an excellent allergen inhibitory effect to the allergen object. Even if the allergen object is a fiber product or a fiber such as a fabric colored with a pigment such as a pigment or a dye, the allergen object treated with the allergen inhibitor is rubbed with the other product to give a color to the other product. There is no transfer. Therefore, it is possible to prevent the color fading of the allergen object due to the color transfer to another product and the contamination of the other product due to the color transfer from the allergen object.
 以下に実施例を挙げて本発明の態様を更に詳しく説明するが、本発明はこれら実施例にのみ限定されるものではない。 Hereinafter, the embodiments of the present invention will be described in more detail with reference to examples. However, the present invention is not limited to these examples.
(実施例1)
 撹拌機、冷却器及び温度計を配設した2リットルのセパラブルフラスコにp-スチレンスルホン酸ナトリウム(東ソー社製 商品名「スピノマー NaSS」、純度:88.2重量%)67重量部、脱イオン水312重量部、スチレンモノマー(和光純薬社製 商品名「スチレン,モノマー」)135重量部及び変性エタノール(和光純薬社製 商品名「86%エタノール-ME,変性」)407重量部を加えて撹拌しながら窒素ガスで置換した後、加熱して78℃に維持した。
Example 1
A 2-liter separable flask equipped with a stirrer, a cooler and a thermometer, 67 parts by weight of sodium p-styrenesulfonate (trade name “Spinomer NaSS” manufactured by Tosoh Corporation, purity: 88.2% by weight), deionized 312 parts by weight of water, 135 parts by weight of styrene monomer (trade name “styrene, monomer” manufactured by Wako Pure Chemical Industries, Ltd.) and 407 parts by weight of modified ethanol (trade name “86% ethanol-ME, modified” manufactured by Wako Pure Chemical Industries, Ltd.) were added. The mixture was replaced with nitrogen gas while stirring, and then heated and maintained at 78 ° C.
 ペリオキソ二硫酸カリウム(和光純薬社製)4.4重量部を脱イオン水95重量部に溶解させてなる重合開始剤溶液を15分かけてセパラブルフラスコ内に添加後、5時間に亘ってスチレンモノマーとp-スチレンスルホン酸ナトリウムとを重合させた。 A polymerization initiator solution prepared by dissolving 4.4 parts by weight of potassium peroxodisulfate (manufactured by Wako Pure Chemical Industries, Ltd.) in 95 parts by weight of deionized water was added to the separable flask over 15 minutes, and then over 5 hours. Styrene monomer and sodium p-styrene sulfonate were polymerized.
 しかる後、反応溶液を乾燥させて重合体を得た。得られた重合体50重量部をイオン交換水500重量部に分散させて分散液を作製し、この分散液をスターラーで撹拌しながら分散液のpHが8.5になるように水酸化ナトリウムを分散液に添加し、分散液を5時間に亘って撹拌した後、分散液から重合体を分離濾過した後に乾燥させてp-スチレンスルホン酸ナトリウム-スチレンランダム共重合体を得た。なお、p-スチレンスルホン酸ナトリウム-スチレンランダム共重合体において、p-スチレンスルホン酸ナトリウム成分は30.4重量%、スチレン成分は69.6重量%であった。p-スチレンスルホン酸ナトリウム-スチレンランダム共重合体の重量平均分子量は9万であった。p-スチレンスルホン酸ナトリウム-スチレンランダム共重合体の平均粒子径は2μmであった。 Thereafter, the reaction solution was dried to obtain a polymer. 50 parts by weight of the obtained polymer was dispersed in 500 parts by weight of ion-exchanged water to prepare a dispersion, and sodium hydroxide was added so that the pH of the dispersion became 8.5 while stirring the dispersion with a stirrer. After adding to the dispersion and stirring the dispersion for 5 hours, the polymer was separated from the dispersion, filtered and dried to obtain a p-sodium styrenesulfonate-styrene random copolymer. In the p-sodium styrenesulfonate-styrene random copolymer, the sodium p-styrenesulfonate component was 30.4% by weight and the styrene component was 69.6% by weight. The weight average molecular weight of the p-sodium styrenesulfonate-styrene random copolymer was 90,000. The average particle size of the p-sodium styrenesulfonate-styrene random copolymer was 2 μm.
 市販されている黒色の生地A(無地ツイル生地(綿100重量%))及び黒色の生地B(T/Cブロード生地(ポリエステル:65重量%,綿:35重量%))をそれぞれ、縦5cm×横20cmの平面長方形状に切断した。 Commercially available black fabric A (plain twill fabric (cotton 100% by weight)) and black fabric B (T / C broad fabric (polyester: 65% by weight, cotton: 35% by weight)), each 5 cm in length It was cut into a flat rectangular shape with a width of 20 cm.
 上記で得られたp-スチレンスルホン酸ナトリウム-スチレンランダム共重合体2重量%とアクリル系バインダー(DIC社製 商品名「ボンコートAC-501」)2重量%とを水中に分散させてなる処理水溶液に、平面長方形状の黒色の生地A,Bをそれぞれ5分間に亘って浸漬した後、黒色の生地A,Bから余分な水分を取り除き、黒色の生地A,Bを150℃にて3分に亘って乾燥して試験片A,Bを得た。黒色の生地A,B100重量部のそれぞれにp-スチレンスルホン酸ナトリウム-スチレンランダム共重合体1重量部が含浸されていた。 Treatment aqueous solution in which 2% by weight of the sodium p-styrenesulfonate-styrene random copolymer obtained above and 2% by weight of an acrylic binder (trade name “Boncoat AC-501” manufactured by DIC) are dispersed in water. Then, after the flat rectangular black fabrics A and B were soaked for 5 minutes, excess water was removed from the black fabrics A and B, and the black fabrics A and B were removed at 150 ° C. for 3 minutes. It dried over and obtained the test pieces A and B. Each of 100 parts by weight of black fabrics A and B was impregnated with 1 part by weight of a p-sodium styrenesulfonate-styrene random copolymer.
(実施例2)
 p-スチレンスルホン酸ナトリウムを93.2重量部に、スチレンモノマーを110重量部に、ペリオキソ二硫酸カリウム4.05重量部に変更したこと以外は、実施例1と同様の要領で、p-スチレンスルホン酸ナトリウム-スチレンランダム共重合体を得た。なお、p-スチレンスルホン酸ナトリウム-スチレンランダム共重合体において、p-スチレンスルホン酸ナトリウム成分は42.8重量%、スチレン成分は57.2重量%であった。p-スチレンスルホン酸ナトリウム-スチレンランダム共重合体の重量平均分子量は8万であった。p-スチレンスルホン酸ナトリウム-スチレンランダム共重合体の平均粒子径は1μmであった。実施例1と同様の要領で試験片A,Bを得た。
(Example 2)
In the same manner as in Example 1, except that sodium p-styrenesulfonate was changed to 93.2 parts by weight, styrene monomer to 110 parts by weight, and potassium peroxodisulfate to 4.05 parts by weight, p-styrene was used. A sodium sulfonate-styrene random copolymer was obtained. In the p-sodium styrenesulfonate-styrene random copolymer, the sodium p-styrenesulfonate component was 42.8% by weight and the styrene component was 57.2% by weight. The weight average molecular weight of the p-sodium styrenesulfonate-styrene random copolymer was 80,000. The average particle size of the p-sodium styrenesulfonate-styrene random copolymer was 1 μm. Test piece A in the same manner as in Example 1 to obtain a B.
(実施例3)
 p-スチレンスルホン酸ナトリウムの代わりにp-スチレンスルホン酸アンモニウム塩を95.2重量部用いたこと、スチレンモノマーを50重量部に変更したこと、ペリオキソ二硫酸カリウムを4.05重量部に変更したこと、pH調整のために水酸化ナトリウムの代わりに25重量%のアンモニア水を用いたこと以外は、実施例1と同様の要領で、p-スチレンスルホン酸アンモニウム-スチレンランダム共重合体を得た。なお、p-スチレンスルホン酸アンモニウム-スチレンランダム共重合体において、p-スチレンスルホン酸アンモニウム成分は43.2重量%、スチレン成分は56.8重量%であった。p-スチレンスルホン酸アンモニウム-スチレンランダム共重合体の重量平均分子量は9万であった。p-スチレンスルホン酸アンモニウム-スチレンランダム共重合体の平均粒子径は2μmであった。p-スチレンスルホン酸アンモニウム-スチレンランダム共重合体をp-スチレンスルホン酸ナトリウム-スチレンランダム共重合体の代わりに用いたこと以外は実施例1と同様の要領で試験片A,Bを得た。
(Example 3)
95.2 parts by weight of ammonium p-styrene sulfonate was used instead of sodium p-styrene sulfonate, styrene monomer was changed to 50 parts by weight, and potassium peroxodisulfate was changed to 4.05 parts by weight. A p-styrene sulfonic acid ammonium-styrene random copolymer was obtained in the same manner as in Example 1 except that 25 wt% aqueous ammonia was used instead of sodium hydroxide for pH adjustment. . In the p-styrene ammonium sulfonate-styrene random copolymer, the ammonium p-styrene sulfonate component was 43.2% by weight and the styrene component was 56.8% by weight. The weight average molecular weight of the p-ammonium styrenesulfonate-styrene random copolymer was 90,000. The average particle size of the p-ammonium styrenesulfonate-styrene random copolymer was 2 μm. Specimens A and B were obtained in the same manner as in Example 1, except that p-ammonium styrenesulfonate-styrene random copolymer was used instead of p-sodium styrenesulfonate-styrene random copolymer.
(実施例4)
 実施例1と同様の要領で得られたpH調整前の重合体50重量部をイオン交換水500重量部に分散させて分散液を作製し、この分散液をスターラーで撹拌しながら分散液のpHが5.5になるように塩酸を分散液に添加し、分散液を5時間に亘って撹拌した後、分散液から重合体を分離濾過した後に乾燥させてp-スチレンスルホン酸ナトリウム-p-スチレンスルホン酸-スチレンランダム共重合体を得た。なお、p-スチレンスルホン酸ナトリウム-p-スチレンスルホン酸-スチレンランダム共重合体において、p-スチレンスルホン酸ナトリウム成分は27.7重量%、p-スチレンスルホン酸成分は2.7重量%、スチレン成分は69.6重量%であった。p-スチレンスルホン酸ナトリウム-p-スチレンスルホン酸-スチレンランダム共重合体の重量平均分子量は9万であった。p-スチレンスルホン酸ナトリウム-p-スチレンスルホン酸-スチレンランダム共重合体の平均粒子径は2μmであった。p-スチレンスルホン酸ナトリウム-p-スチレンスルホン酸-スチレンランダム共重合体をp-スチレンスルホン酸ナトリウム-スチレンランダム共重合体の代わりに用いたこと以外は実施例1と同様の要領で試験片A,Bを得た。p-スチレンスルホン酸ナトリウム-p-スチレンスルホン酸-スチレンランダム共重合体中におけるp-スチレンスルホン酸ナトリウム及びp-スチレンスルホン酸の総含有量を表1の「p-スチレンスルホン酸塩成分の含有量」の欄に便宜上、記載した。
Example 4
50 parts by weight of the polymer before pH adjustment obtained in the same manner as in Example 1 was dispersed in 500 parts by weight of ion-exchanged water to prepare a dispersion, and this dispersion was stirred with a stirrer to adjust the pH of the dispersion. Hydrochloric acid was added to the dispersion so as to be 5.5, and the dispersion was stirred for 5 hours, and then the polymer was separated from the dispersion, filtered, and dried to obtain p-sodium styrenesulfonate-p- A styrene sulfonic acid-styrene random copolymer was obtained. In the p-sodium styrenesulfonate-p-styrenesulfonate-styrene random copolymer, the sodium p-styrenesulfonate component was 27.7% by weight, the p-styrenesulfonate component was 2.7% by weight, styrene The component was 69.6% by weight. The weight average molecular weight of p-sodium styrenesulfonate-p-styrenesulfonate-styrene random copolymer was 90,000. The average particle size of the p-sodium styrenesulfonate-p-styrenesulfonate-styrene random copolymer was 2 μm. Specimen A in the same manner as in Example 1 except that p-sodium styrenesulfonate-p-styrenesulfonic acid-styrene random copolymer was used instead of p-sodium styrenesulfonate-styrene random copolymer. , B was obtained. The total content of sodium p-styrene sulfonate and p-styrene sulfonic acid in the p-sodium styrene sulfonate-p-styrene sulfonate-styrene random copolymer is shown in Table 1 “Content of p-styrene sulfonate component”. For convenience, it is shown in the column “Amount”.
(比較例1)
 p-スチレンスルホン酸ナトリウムを37重量部に、スチレンモノマーを155重量部に、ペリオキソ二硫酸カリウム4.5重量部に変更したこと以外は、実施例1と同様の要領で、p-スチレンスルホン酸ナトリウム-スチレンランダム共重合体を得た。なお、p-スチレンスルホン酸ナトリウム-スチレンランダム共重合体において、p-スチレンスルホン酸ナトリウム成分は17.4重量%、スチレン成分は82.6重量%であった。p-スチレンスルホン酸ナトリウム-スチレンランダム共重合体の重量平均分子量は8万であった。p-スチレンスルホン酸ナトリウム-スチレンランダム共重合体の平均粒子径は3μmであった。実施例1と同様の要領で試験片A,Bを得た。
(Comparative Example 1)
In the same manner as in Example 1, except that sodium p-styrenesulfonate was changed to 37 parts by weight, the styrene monomer was changed to 155 parts by weight, and potassium peroxodisulfate was changed to 4.5 parts by weight, p-styrenesulfonic acid was used. A sodium-styrene random copolymer was obtained. In the p-sodium styrenesulfonate-styrene random copolymer, the p-sodium styrenesulfonate component was 17.4% by weight and the styrene component was 82.6% by weight. The weight average molecular weight of the p-sodium styrenesulfonate-styrene random copolymer was 80,000. The average particle size of the p-sodium styrenesulfonate-styrene random copolymer was 3 μm. Test piece A in the same manner as in Example 1 to obtain a B.
(比較例2)
 p-スチレンスルホン酸ナトリウムを100重量部に、スチレンを93重量部に、ペリオキソ二硫酸カリウムを3.73重量部に変更したこと以外は、実施例1と同様の要領でp-スチレンスルホン酸ナトリウム-スチレンランダム共重合体を得た。なお、p-スチレンスルホン酸ナトリウム-スチレンランダム共重合体において、p-スチレンスルホン酸ナトリウム成分は48.6重量%、スチレン成分は51.4重量%であった。p-スチレンスルホン酸ナトリウム-スチレンランダム共重合体の重量平均分子量は10万であった。p-スチレンスルホン酸ナトリウム-スチレンランダム共重合体の平均粒子径は1μmであった。実施例1と同様の要領で試験片A,Bを得た。
(Comparative Example 2)
Sodium p-styrenesulfonate in the same manner as in Example 1 except that sodium p-styrenesulfonate was changed to 100 parts by weight, styrene was changed to 93 parts by weight, and potassium peroxodisulfate was changed to 3.73 parts by weight. -A styrene random copolymer was obtained. In the p-sodium styrenesulfonate-styrene random copolymer, the sodium p-styrenesulfonate component was 48.6% by weight and the styrene component was 51.4% by weight. The weight average molecular weight of the p-sodium styrenesulfonate-styrene random copolymer was 100,000. The average particle size of the p-sodium styrenesulfonate-styrene random copolymer was 1 μm. Test piece A in the same manner as in Example 1 to obtain a B.
(比較例3)
 市販されている黒色の生地A(無地ツイル生地(綿100重量%))及び黒色の生地B(T/Cブロード生地(ポリエステル:65重量%,綿:35重量%))をそれぞれ、縦5cm×横20cmの平面長方形状に切断した。
(Comparative Example 3)
Commercially available black fabric A (plain twill fabric (cotton 100% by weight)) and black fabric B (T / C broad fabric (polyester: 65% by weight, cotton: 35% by weight)), each 5 cm in length It was cut into a flat rectangular shape with a width of 20 cm.
 アクリル系バインダー(DIC社製 商品名「ボンコートAC-501」)2重量%を水中に分散させてなる処理水溶液に、平面長方形状の黒色の生地A,Bをそれぞれ5分間に亘って浸漬した後、黒色の生地A,Bから余分な水分を取り除き、黒色の生地A,Bを150℃にて3分に亘って乾燥して試験片A,Bを得た。 After dipping the flat rectangular black fabrics A and B for 5 minutes each in a treatment solution in which 2% by weight of an acrylic binder (trade name “Boncoat AC-501” manufactured by DIC Corporation) is dispersed in water Excess water was removed from the black fabrics A and B, and the black fabrics A and B were dried at 150 ° C. for 3 minutes to obtain test pieces A and B.
 実施例及び比較例で得られた試験片A,Bについて、下記の要領にてアレルゲン抑制効果及び色移行性を測定し、その結果を表1に示した。 The test pieces A and B obtained in the examples and comparative examples were measured for the allergen suppressing effect and color transferability in the following manner, and the results are shown in Table 1.
(初期アレルゲン抑制効果)
 アレルゲンの冷結乾燥粉末(コスモ・バイオ社製商品名「MiteExtract-Df」)をリン酸バッファー(pH7.6)に溶解させて、タンパク量が20μg/ミリリットルのアレルゲン水溶液を調製した。
(Initial allergen suppression effect)
An allergen chilled dry powder (trade name “MiteExtract-Df” manufactured by Cosmo Bio Inc.) was dissolved in a phosphate buffer (pH 7.6) to prepare an allergen aqueous solution having a protein amount of 20 μg / ml.
 実施例及び比較例で得られた試験片A,Bのそれぞれから縦1cm×横5cmの平面長方形状の評価サンプルA,Bを切り出した。上記アレルゲン水溶液を3ミリリットルづつ供給した試験管を用意した。評価用サンプルA,Bをそれぞれ別々の試験管に添加して37℃で24時間に亘って振盪した。 Evaluation samples A and B each having a rectangular shape of 1 cm in length and 5 cm in width were cut out from each of the test pieces A and B obtained in Examples and Comparative Examples. A test tube to which 3 ml of the allergen aqueous solution was supplied was prepared. Samples A and B for evaluation were added to separate test tubes and shaken at 37 ° C. for 24 hours.
 次に、試験管内のアレルゲン水溶液100マイクロリットルを、アレルゲン測定具(住化エンビロサイエンス社製商品名「マイティーチェッカー」)に添加し、アレルゲン測定具の発色度合いを目視観察して下記の基準により初期のアレルゲン抑制効果を評価した。アレルゲン測定具の発色が濃いほどアレルゲンが液中に濃い濃度で存在している。なお、アレルゲン抑制効果としては、下記の1から3判定を合格とした。
 5・・・濃く、太くはっきりとしたラインが観測された。
 4・・・ラインであることがはっきりと分かる。
 3・・・ライン状にうっすらと発色している。
 2・・・うっすらと発色している。
 1・・・全く発色していない。
Next, 100 microliters of the allergen aqueous solution in the test tube is added to the allergen measuring device (trade name “Mighty Checker” manufactured by Sumika Enviro Science Co., Ltd.) The initial allergen inhibitory effect was evaluated. The darker the color of the allergen measuring device, the more allergen is present in the liquid. In addition, as an allergen suppression effect, the following 1 to 3 determination was set as the pass.
5 ... A thick, thick and clear line was observed.
4 ... It can be clearly seen that it is a line.
It is coloring faintly in 3 ... line shape.
2 ... The color is faintly colored.
1 ... No color development at all.
(耐久アレルゲン抑制効果)
 初期アレルゲン抑制効果の評価と同様の要領で評価サンプルA,Bを作製した。この評価サンプルA,Bをそれぞれ、25℃に保持された200ミリリットルの水に別々に1分間に亘って浸漬して取り出し、各評価用サンプルA,Bを100℃にて10分間に亘って乾燥した。この評価サンプル片A,Bについて、上述と同様の要領にて、アレルゲン抑制効果を測定した。
(Durable allergen suppression effect)
Evaluation samples A and B were prepared in the same manner as the evaluation of the initial allergen inhibitory effect. Each of these evaluation samples A and B was separately immersed in 200 ml of water kept at 25 ° C. for 1 minute and taken out, and each of the evaluation samples A and B was dried at 100 ° C. for 10 minutes. did. For the evaluation sample pieces A and B, the allergen suppressing effect was measured in the same manner as described above.
(色移行性)
 実施例及び比較例で得られた試験片をJIS L0849に準拠した方法で、乾燥した綿布を用いて往復100回での色移行性を1から5の5段で評価した。5が優秀で綿布への汚染が激しくなるほど数字が小さくなる。
(Color transfer)
The test pieces obtained in the examples and comparative examples were evaluated in 5 steps from 1 to 5 in terms of color transferability in 100 round trips using a dry cotton cloth in accordance with JIS L0849. The number becomes smaller as 5 is better and the contamination of the cotton cloth becomes more severe.
Figure JPOXMLDOC01-appb-T000006
Figure JPOXMLDOC01-appb-T000006
 本発明のアレルゲン抑制剤は、優れたアレルゲン抑制効果を有すると共に、不測の変色が生じにくく、色移りも生じがたい。従って、本発明のアレルゲン抑制剤は、生活用品などのアレルゲン対象物にアレルゲン抑制効果を容易に与えることができる。更に、本発明のアレルゲン抑制剤は、不測の着色や、日常の生活環境における変色が殆どなく、更に、色移りの問題も殆どないことから、光による退色、変色、又は、擦れによる他製品への色移りによる汚染が課題となる用途、例えば、繊維製品、建築内装材、車輛内用品、車輛内装材、フィルターなどの用途に好適に用いることができる。 The allergen inhibitor of the present invention has an excellent allergen suppressing effect, is unlikely to cause unexpected discoloration, and hardly causes color transfer. Therefore, the allergen inhibitor of the present invention can easily give an allergen inhibitory effect to an allergen object such as daily necessities. Furthermore, since the allergen inhibitor of the present invention has almost no unexpected coloration or discoloration in the daily living environment, and there is almost no problem of color transfer, it can be used for other products caused by light fading, discoloration, or rubbing. It can be suitably used for applications in which contamination due to color transfer is a problem, such as textile products, building interior materials, in-car accessories, vehicle interior materials, and filters.

Claims (19)

  1. 一般式(1)で示される構造式の単量体成分を20~45重量%含有するスチレン系重合体を含有していることを特徴とするアレルゲン抑制剤。
    Figure JPOXMLDOC01-appb-C000001

    (R1~R5はそれぞれ、水素、スルホン酸基又はスルホン酸基の塩の何れかであって、R1~R5のうちの少なくとも一つは、スルホン酸基又はスルホン酸基の塩である。)
    An allergen inhibitor comprising a styrenic polymer containing 20 to 45% by weight of a monomer component having the structural formula represented by the general formula (1).
    Figure JPOXMLDOC01-appb-C000001

    (R 1 to R 5 are each hydrogen, a sulfonic acid group or a sulfonic acid group salt, and at least one of R 1 to R 5 is a sulfonic acid group or a sulfonic acid group salt. is there.)
  2. 3がスルホン酸基の一価の塩であることを特徴とする請求項1に記載のアレルゲン抑制剤。 The allergen inhibitor according to claim 1, wherein R 3 is a monovalent salt of a sulfonic acid group.
  3. 3が-SO3Na又は-SO3 NH4 +であることを特徴とする請求項2に記載のアレルゲン抑制剤。 Allergen inhibitor according to claim 2, characterized in that the NH 4 + - R 3 is -SO 3 Na or -SO 3.
  4. スチレン系重合体は、スチレンスルホン酸塩-スチレン共重合体、スチレンスルホン酸塩-スチレンスルホン酸-スチレン三元共重合体及びポリスチレンのスルホン化体からなる群から選ばれた少なくとも一種の重合体であることを特徴とする請求項1に記載のアレルゲン抑制剤。 The styrenic polymer is at least one polymer selected from the group consisting of a styrene sulfonate-styrene copolymer, a styrene sulfonate-styrene sulfonic acid-styrene terpolymer and a sulfonated polystyrene. The allergen inhibitor according to claim 1, wherein the allergen inhibitor is present.
  5. 請求項1乃至請求項4の何れか1項に記載のアレルゲン抑制剤をアレルゲン対象物に処理してなることを特徴とするアレルゲン抑制製品。 An allergen-suppressing product obtained by treating the allergen inhibitor according to any one of claims 1 to 4 with an allergen object.
  6. アレルゲン対象物が繊維又は繊維製品であることを特徴とする請求項5に記載のアレルゲン抑制製品。 6. The allergen-suppressing product according to claim 5, wherein the allergen object is a fiber or a fiber product.
  7. 一般式(1)で示される構造式の単量体成分を20~45重量%含有するスチレン系重合体を含有しているアレルゲン抑制剤をアレルゲン対象物に供給して、上記アレルゲン対象物にアレルゲン抑制効果を付与することを特徴とするアレルゲンの抑制方法。
    Figure JPOXMLDOC01-appb-C000002

    (R1~R5はそれぞれ、水素、スルホン酸基又はスルホン酸基の塩の何れかであって、R1~R5のうちの少なくとも一つは、スルホン酸基又はスルホン酸基の塩である。)
    An allergen inhibitor containing a styrene polymer containing 20 to 45% by weight of a monomer component of the structural formula represented by the general formula (1) is supplied to the allergen object, and the allergen object is supplied with the allergen method for inhibiting allergens, which comprises applying an inhibitory effect.
    Figure JPOXMLDOC01-appb-C000002

    (R 1 to R 5 are each hydrogen, a sulfonic acid group or a sulfonic acid group salt, and at least one of R 1 to R 5 is a sulfonic acid group or a sulfonic acid group salt. is there.)
  8. アレルゲン対象物にアレルゲンが存在し、アレルゲン抑制剤によって上記アレルゲンを抑制することを特徴とする請求項7に記載のアレルゲンの抑制方法。 The allergen suppression method according to claim 7, wherein the allergen is present in the allergen object, and the allergen is suppressed by an allergen inhibitor.
  9. 3がスルホン酸基の一価の塩であることを特徴とする請求項7に記載のアレルゲンの抑制方法。 The method for inhibiting allergens according to claim 7, wherein R 3 is a monovalent salt of a sulfonic acid group.
  10. 3が-SO3Na又は-SO3 NH4 +であることを特徴とする請求項9に記載のアレルゲンの抑制方法。 Method for inhibiting allergens according to claim 9, characterized in that the NH 4 + - R 3 is -SO 3 Na or -SO 3.
  11. スチレン系重合体は、スチレンスルホン酸塩-スチレン共重合体、スチレンスルホン酸塩-スチレンスルホン酸-スチレン三元共重合体及びポリスチレンのスルホン化体からなる群から選ばれた少なくとも一種の重合体であることを特徴とする請求項7に記載のアレルゲンの抑制方法。 The styrenic polymer is at least one polymer selected from the group consisting of a styrene sulfonate-styrene copolymer, a styrene sulfonate-styrene sulfonic acid-styrene terpolymer and a sulfonated polystyrene. The method for suppressing allergen according to claim 7, wherein
  12. 一般式(1)で示される構造式の単量体成分を20~45重量%含有するスチレン系重合体のアレルゲン抑制剤としての使用。
    Figure JPOXMLDOC01-appb-C000003

    (R1~R5はそれぞれ、水素、スルホン酸基又はスルホン酸基の塩の何れかであって、R1~R5のうちの少なくとも一つは、スルホン酸基又はスルホン酸基の塩である。)
    Use of a styrenic polymer containing 20 to 45% by weight of a monomer component represented by the general formula (1) as an allergen inhibitor.
    Figure JPOXMLDOC01-appb-C000003

    (R 1 to R 5 are each hydrogen, a sulfonic acid group or a sulfonic acid group salt, and at least one of R 1 to R 5 is a sulfonic acid group or a sulfonic acid group salt. is there.)
  13. 3がスルホン酸基の一価の塩であることを特徴とする請求項12に記載のアレルゲン抑制剤としての使用。 The use as an allergen inhibitor according to claim 12, wherein R 3 is a monovalent salt of a sulfonic acid group.
  14. 3が-SO3Na又は-SO3 NH4 +であることを特徴とする請求項13に記載のアレルゲン抑制剤としての使用。 Use as an allergen inhibitor according to claim 13, characterized in that R 3 is -SO 3 Na or -SO 3 - NH 4 + .
  15. スチレン系重合体は、スチレンスルホン酸塩-スチレン共重合体、スチレンスルホン酸塩-スチレンスルホン酸-スチレン三元共重合体及びポリスチレンのスルホン化体からなる群から選ばれた少なくとも一種の重合体であることを特徴とする請求項12に記載のアレルゲン抑制剤としての使用。 The styrenic polymer is at least one polymer selected from the group consisting of a styrene sulfonate-styrene copolymer, a styrene sulfonate-styrene sulfonic acid-styrene terpolymer and a sulfonated polystyrene. Use as an allergen inhibitor according to claim 12, characterized in that it is.
  16. 一般式(1)で示される構造式の単量体成分を20~45重量%含有するスチレン系重合体のアレルゲンを変性し又は吸着するための使用。
    Figure JPOXMLDOC01-appb-C000004

    (R1~R5はそれぞれ、水素、スルホン酸基又はスルホン酸基の塩の何れかであって、R1~R5のうちの少なくとも一つは、スルホン酸基又はスルホン酸基の塩である。)
    Use for modifying or adsorbing an allergen of a styrenic polymer containing 20 to 45% by weight of a monomer component of the structural formula represented by the general formula (1).
    Figure JPOXMLDOC01-appb-C000004

    (R 1 to R 5 are each hydrogen, a sulfonic acid group or a sulfonic acid group salt, and at least one of R 1 to R 5 is a sulfonic acid group or a sulfonic acid group salt. is there.)
  17. 3がスルホン酸基の一価の塩であることを特徴とする請求項16に記載の使用。 Use according to claim 16 wherein R 3, characterized in that a monovalent salt of a sulfonic acid group.
  18. 3が-SO3Na又は-SO3 NH4 +であることを特徴とする請求項17に記載の使用。 Use according to claim 17, characterized in that R 3 is -SO 3 Na or -SO 3 - NH 4 + .
  19. スチレン系重合体は、スチレンスルホン酸塩-スチレン共重合体、スチレンスルホン酸塩-スチレンスルホン酸-スチレン三元共重合体及びポリスチレンのスルホン化体からなる群から選ばれた少なくとも一種の重合体であることを特徴とする請求項16に記載の使用。 The styrenic polymer is at least one polymer selected from the group consisting of a styrene sulfonate-styrene copolymer, a styrene sulfonate-styrene sulfonic acid-styrene terpolymer and a sulfonated polystyrene. Use according to claim 16, characterized in that it is.
PCT/JP2013/052971 2012-02-10 2013-02-08 Allergen inhibitor, allergen-inhibiting product, allergen inhibition method, and use as allergen inhibitor WO2013118852A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2012-027717 2012-02-10
JP2012027717A JP2015078249A (en) 2012-02-10 2012-02-10 Allergen inhibitor and allergen inhibitor product

Publications (1)

Publication Number Publication Date
WO2013118852A1 true WO2013118852A1 (en) 2013-08-15

Family

ID=48947607

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2013/052971 WO2013118852A1 (en) 2012-02-10 2013-02-08 Allergen inhibitor, allergen-inhibiting product, allergen inhibition method, and use as allergen inhibitor

Country Status (2)

Country Link
JP (1) JP2015078249A (en)
WO (1) WO2013118852A1 (en)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006257376A (en) * 2005-02-16 2006-09-28 Sekisui Chem Co Ltd Aqueous allergen-inhibiting agent and allergen-inhibiting fiber product
WO2009078449A1 (en) * 2007-12-17 2009-06-25 Sekisui Chemical Co., Ltd. Allergen inhibitor, allergen-inhibiting product, allergen inhibition method, and use as allergen inhibitor
JP2009155453A (en) * 2007-12-26 2009-07-16 Kao Corp Allergen inactivator
JP2012001631A (en) * 2010-06-16 2012-01-05 Sekisui Chem Co Ltd Allergen inhibitor, and allergen-inhibiting product
JP2012036362A (en) * 2010-07-13 2012-02-23 Sekisui Chem Co Ltd Allergen inhibitor, coating material, and decorative sheet

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006257376A (en) * 2005-02-16 2006-09-28 Sekisui Chem Co Ltd Aqueous allergen-inhibiting agent and allergen-inhibiting fiber product
WO2009078449A1 (en) * 2007-12-17 2009-06-25 Sekisui Chemical Co., Ltd. Allergen inhibitor, allergen-inhibiting product, allergen inhibition method, and use as allergen inhibitor
JP2009155453A (en) * 2007-12-26 2009-07-16 Kao Corp Allergen inactivator
JP2012001631A (en) * 2010-06-16 2012-01-05 Sekisui Chem Co Ltd Allergen inhibitor, and allergen-inhibiting product
JP2012036362A (en) * 2010-07-13 2012-02-23 Sekisui Chem Co Ltd Allergen inhibitor, coating material, and decorative sheet

Also Published As

Publication number Publication date
JP2015078249A (en) 2015-04-23

Similar Documents

Publication Publication Date Title
JP5374464B2 (en) Allergen inhibitor, allergen suppressing product, and allergen suppressing method
JP2010280909A5 (en)
JP4928093B2 (en) Water-based allergen inhibitor and allergen-suppressed fiber product
JP5150763B2 (en) Influenza virus infection inhibitor and influenza virus infection prevention product
JP2010031069A (en) Allergen inhibitor and allergen inhibited product
JP2006304708A (en) Allergen-inhibiting compound and method for producing the same
JP2012001631A (en) Allergen inhibitor, and allergen-inhibiting product
WO2013118852A1 (en) Allergen inhibitor, allergen-inhibiting product, allergen inhibition method, and use as allergen inhibitor
WO2013118853A1 (en) Allergen inhibitor, allergen-inhibiting product, allergen inhibition method, and use as allergen inhibitor
JP4278553B2 (en) Allergen inhibitor
JP5238200B2 (en) Allergen inhibitor and allergen inhibitor product
KR101547787B1 (en) Influenza virus infection inhibitor for fiber processing, fiber product using same, and production method therefor
JP2008169301A (en) Allergen controlling product and allergen controlling composition
JP2005053820A (en) Aqueous allergen reducing agent and method for producing the same
JP4278562B2 (en) Allergen inhibitor
JP2006321858A (en) Allergen rebuffing agent
WO2001096433A1 (en) Use of polymers containing urethane and/or urea groups for the modification of surfaces
JP6904521B2 (en) Allergen reduction composition
WO2024043320A1 (en) Viral infection inhibitor, viral infection inhibition product, and method for manufacturing viral infection inhibition product
TW202425958A (en) Allergen inhibitor and allergen inhibition product
Cerkez Bursa Technical University, Bursa, Turkey
JP2006063298A (en) Method for producing suspension
JP2008239862A (en) Allergen-inhibiting ability restoration agent
CN117286713A (en) Antibacterial flame-retardant textile auxiliary, and preparation method and application thereof
JP2010132715A (en) Amino group-containing particles, method for producing the same and functional product containing the particles

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 13746827

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 13746827

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: JP